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Outer membrane vesicles (OMVs) are nano­sized proteoliposomes ubiquitously               
released from the outer membrane of Gram­negative bacteria, and are known to                       
contribute to immune priming and disease pathogenesis. However, the current                   
understanding of their interactions with host cells is limited by a lack of                         
methods to study the rapid kinetics of vesicle entry and cargo delivery. This                         
work has developed a highly sensitive method to study vesicle entry into host                         
cells in real­time using a genetically encoded, vesicle­targeted probe. Using this                     
approach, it was found that the route of vesicular uptake, and thus entry kinetics                           
and efficiency, are shaped by bacterial cell wall composition. The presence of O                         
polysaccharide in lipopolysaccharide creates a bias towards non­receptor               
mediated endocytosis, which enhances both the rate and efficiency of entry into                       
host cells. This work indicates that the composition of the bacterial cell wall                         
influences the behaviour of OMVs, and is therefore implicated in                   
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Communication is a vital aspect of bacterial life, allowing bacteria to interact with and                           
react to their environment. Secretion of cellular material represents a versatile means of                         
communication, and there are numerous mechanisms employed by bacteria in order to                       





The discovery of the immunogenic properties and detection of LPS in cell free                         
supernatants from  Vibrio cholerae and  Escherichia coli over 50 years ago led to the                           
observation of small membranous spherical structures via electron microscopy that later                     
became known as Outer Membrane Vesicles (OMVs) (De, 1959; Bishop and Work,                       
1965). OMVs are nanosized (20­200 nm) spherical membranous structures that are                     
observed to pinch off from all areas of the outer membrane of the bacterial cell, and                               
contain LPS, and some inner membrane and periplasmic components (Devoe and                     
Glichrist, 1973; Beveridge et al, 1999). Their ubiquitous production by all species of                         
Gram negative bacteria studied to date, and in all growth phases and environmental                         
conditions caused them to be dismissed as a by­product of cell wall turnover or lysis.                             
Later evidence demonstrated the production of OMVs independently of cell lysis, and                       
showed that they contained newly synthesised cellular material (Mug­Opstelten and                   
Witholt, 1978; McBroom et al, 2006). Subsequent proteomic studies also revealed                     
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 enrichment or exclusion of certain molecules within the vesicles, suggesting a selective                       
and active process of OMV release from the cell (Haurat et al, 2011; Elhenawy et al,                               
2014). The constant production, selectivity of cargo, and energy expenditure all indicate                       





OMV release is now recognised as a form of generalised secretion system, with several                           
advantages over other secretory mechanisms in Gram negative species. OMVs can export                       
considerably more material than other types of secretion, with up to 5% of the outer                             
membrane material of  E. coli  being shed in the form of OMVs, and up to 12% of total                                   
protein content for  Neisseria meningitidis (Devoe and Gilchrist, 1973; Gankema et al,                       
1980). OMV release also allows protection of the cargo molecules within the enclosed                         
lipid membrane, avoiding degradation in the extracellular environment, and also                   
maintaining high concentrations of the substrates upon arrival at their destination                     
(Kolling and Matthews, 1999). Molecules can be secreted within vesicles without                     
requiring particular signal sequences, and can also be secreted alongside other molecules                       




 The continuous production and versatility of OMVs allows them to play diverse roles in                           
bacterial survival. OMVs are implicated in bacterial stress responses via the export of                         
misfolded proteins from the cell, and  E. coli with mutations in the heat shock response                             
pathway σ   showed increased vesiculation, suggesting a compensatory stress response is                     
provided by OMVs (McBroom and Kuehn, 2007). OMV production increases following                     
envelope stress and this increased production is also correlated with increased bacterial                       
survival (McBroom and Kuuehn, 2007; MacDonald and Kuehn, 2013).  
 
Although non­vesiculating mutants have so far been non­viable, hypervesiculating strains                   
have been used to demonstrate the contributions of OMVs to stress responses. A                         
hypervesiculating  yieM mutant strain showed increased survival compared to the                   
wild­type strains after exposure to membrane­acting stressors polymyxin B and colistin,                     
and to T4 phage challenge (Manning and Kuehn, 2011). Treatment with alcohols, metal                         
chelators, heat and osmotic shocks all resulted in increased vesiculation of  Pseudomonas                       





OMV production can also help to adsorb toxic molecules such as antibiotics; gentamicin                         
sensitive clinical isolates of extra­intestinal pathogenic  E. coli (ExPEC) showed a 13.1                       
fold increase in OMV production compared with gentamicin resistant strains (Chan et al,                         
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 2017). Similarly, isolated OMVs from  E. coliMG1655 were able to protect  P. aeruginosa                           
and  Acinetobacter radioresistens against membrane active antibiotics, but not against                   
those with different mechanisms (Kulkarni et al, 2015). The OMVs were shown to                         
contain proteases which degraded the antibiotic melittin, whilst the membrane                   
sequestered colistin, suggesting OMVs are well adapted to protecting a mixed community                       
of bacteria against antibiotic treatment (Kulkarni et al, 2015).  
 
Other contributions to bacterial communities have also been observed. OMVs from  P.                       
aeruginosa have been found to contain β­lactamase, an enzyme able to degrade penicillin                         
antibiotics, and thus benefit not only the cells encoding the β­lactamase but also                         
non­resistant strains occupying the same niche (Ciofu et al, 2000). This effect was                         
observed directly for  Moraxella catarrhalis , which often co­infects the upper respiratory                     
tract with  Haemophilus influenzae and  Streptococcus pneumoniae . The  M. catarrhalis                   
OMVs were found to contain β­lactamase and were able to rescue the                       
amoxicillin­sensitive strains of  H. influenzae and  S. pneumoniae , indicating a clinical                     
implication for OMVs in facilitating antibiotic resistance (Schaar et al, 2011).  
 
OMVs also contribute to group behaviour via the release of quorum sensing molecules.                         
In P. aeruginosa , OMVs were found to contain the hydrophobic pseudomonas quinolone                       
signal, PQS. Removing OMVs from the cultures resulted in a reduction in pyocyanin                         
production, and it was also demonstrated that PQS mutants produced fewer OMVs,                       
suggesting that the OMV cargo initiates OMV production (Mashburn and Whiteley,                     
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 2005). This was later shown to be due to its ability to induce membrane curvature, and                               
promote OMV release from the cell envelope (Mashburn­Warren et al, 2008). PQS is able                           
to bind iron, an essential and often scarce nutrient, and so release of OMV­associated                           
PQS may enable the Pseudomonas population access to a higher concentration of iron in                           
the extracellular environment (Kulp and Kuehn, 2010). It was recently demonstrated that                       
OMVs enabled iron uptake and compensated for loss of other iron acquisition systems in                           
mutant strains of  P. aeruginosa (Lin et al, 2017).  
 
OMVs from  Bacteroides succinogenes were observed to bind and degrade cellulose in                       
the rumen, and therefore aid in digestion of the large polymer and provide a source of                               
sugars for species which lacked their own cellulolytic enzymes, and resulted in a stable                           
microbial population (Forsberg et al, 1981).  
 
Not all OMVs are beneficial to communities. OMVs from the soil dwelling predatory                         
bacterium  Myxococcus xanthus were shown to contain unique cargo molecules including                     
proteases and phosphatases and selectively target  E. coli cells and cause cell death (Evans                           
et al, 2012; Berleman et al, 2014). A study by Li et al (1998) isolated OMVs from 15                                   
different strains of Gram negatives, and demonstrated their ability to lyse a range of                           
target cells, both Gram negative and Gram positive. The OMVs were most effective at                           






OMVs have also been shown to export nucleic acids, with the DNA protected from                           
degradation and resistant to DNAse (Kahn et al, 1983). DNA was detected in vesicles                           
produced by enterohaemorrhagic  E. coli (EHEC) encoding several virulence factors and                     
resistance genes. The genetic material was efficiently transferred to the non­virulent  E.                       
coli JM109 recipient strains, conveying antibiotic resistance and increasing their                   
cytotoxicity 6­fold (Kolling et al, 1999; Yaron et al, 2000). Transfer of resistance genes                           
by OMVs was also observed for  N. meningitidis (Dorward et al, 1989) and  H. influenzae ,                             
where production of OMVs was also correlated with the competence state of the cells                           
(Kahn et al, 1983). 
 
As well as containing and releasing the enzymes which confer antibiotic resistance,                       
OMVs can also transfer the genes which encode them. New Delhi metallo­β­lactamase­1                       
(NDM­1) is an antibiotic resistance gene that confers resistance to almost all penicillins,                         
carbapenems and cephalosporins (Chatterjee et al, 2017). Isolation of OMVs from a                       
clinically resistant strain of  A. baumannii revealed the presence of the NDM­1 gene                         
within the vesicles. Transfer of these vesicles to a non­resistant strain of  A. baumannii                           
and a strain of  E. coli resulted in transfer of resistance, and was determined to be due to                                   
the plasmid encoded NDM­1 transferred by the OMVs (Chatterjee et al, 2017). OMVs                         




OMVs can transfer nucleic acids to mammalian cells. sRNA from  P. aeruginosa OMVs                         
was detected in human airway epithelial cells by RNAseq, and resulted in reduced                         






The contribution of OMVs to bacterial stress responses is well established, and                       
colonisation of a host can be considered a stressful environment (MacDonald and Kuehn,                         
2012). Pathogenic species generally release more OMVs than their non­pathogenic                   
counterparts, with Enterotoxigenic  E. coli secreting up to 10 fold more OMVs than the                           
lab strain HB101 (Horstmann and Kuehn, 2000). Evidence of OMV production in vivo                         
has been documented for many species, and observed via electron microscopy from                       
human tissue biopsies (Fiocca et al, 1999; Heczko, 2000). It is likely that the role of                               
OMVs in host colonisation and pathogenesis has been underestimated clinically, due to                       
their size and their ability to disseminate deep into tissues and to to sites in the body                                 
distant to the initial infection (Dorward et al, 1991; Ellis and Kuehn, 2010). Intracellular                           
pathogens such as  Legionella pneumophila have also been shown to produce OMVs                       
within intracellular compartments such as phagosomes (Fernandez­Moreira et al, 2006)                   
whilst a recombinant  Salmonella enterica Typhimurium strain engineered to express                   
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 Typhoid toxin were found to produce OMVs within the  Salmonella ­containing vacuole                     
(SCV) and these OMVs were able to exit the host cell and deliver the toxin to                               
neighbouring epithelial cells (Guidi et al, 2013). OMVs have been detected in sites                         




One of the most effective ways that pathogens appear to have adapted the use of OMVs is                                 
for the delivery of a wide range of toxins. OMVs from Enterotoxigenic  E. coli  (ETEC)                             
were found to contain heat­labile enterotoxin (LT), which was delivered into intestinal                       
epithelial cells, resulting in cytotoxicity (Kesty and Kuehn, 2004). The major virulence                       
factor of  V. cholerae , the cholera toxin (CT), can be delivered via OMVs into host cells                               
where it causes increased cellular cyclic AMP, resulting in cytotoxicity in human                       
intestinal epithelial cells (Chatterjee and Chaudhuri, 2011). The invasion plasmid                   
antigens IpaB, C and D of  Shigella flexneri are implicated in invasion of epithelial cells                             
and have all been detected in OMVs (Menard, Sansonetti and Parsot, 1993;                       
Kadurugamuwa and Beveridge, 1998). The periodontal pathogen  T. denticola secretes                   
OMVs containing the protease dentilisin, and facilitate disruption and penetration of                     
epithelial layers (Rosen et al, 1995; Chi, Qi and Kuramitsu, 2003). OMVs from the                           
intestinal pathogen  Campylobacter jejuni have been observed to cause cytotoxicity in                     
cultured intestinal cells and in the wax worm larvae  Galleria mellonella .  C. jejuni OMVs                           
have been shown to export cytolethal distending toxin (CDT) and also a number of                           
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 proteases, including HtrA, which is able to bind and cleave the host trans­membrane                         
protein E­cadherin (Elmi et al, 2012; Elmi et al, 2015). Co­culture of HtrA positive                           
OMVs with the live  C. jejuni  resulted in increased bacterial adhesion and intracellular                         
invasion of intestinal epithelial cell monolayers, indicating a role for OMVs in promoting                         
bacterial colonisation and pathogenesis (Elmi et al, 2015). 
 
Many toxins released by bacteria can be exported by OMVs or in their free form; Shiga                               
toxin was detected in OMVs produced by EHEC O157:H7 and  Shigella dysenteriae , with                         
more Shiga toxin detected in the OMVs than in the supernatant or cell pellet (Kolling and                               
Matthews, 1999; Dutta et al, 2004). Caspase mediated apoptosis was observed after                       
delivery of shiga toxin into intestinal epithelial cells from the virulent outbreak strain  E.                           
coli O104:H4 (Kunsmann et al, 2015).  
 
EHEC Hly, a hemolysin, can also be exported in its soluble form or in association with                               
OMVs, and this has different consequences for the target cell. Free EHEC­Hly causes cell                           
lysis, whilst Hly entering cells via OMVs targets the mitochondria, activates caspase­3                       
and caspase­9, triggering apoptosis (Bielaszewska et al, 2013).  
 
Export via OMVs is the preferred route for some bacterial cargo. ClyA is an unusual                             
pore­forming cytolysin expressed by various virulent  E. coli and  S. enterica strains which                         
contains no typical signal sequence for secretion, but its inactive monomers accumulate                       
in the periplasmic space (Wai et al, 2003; Ludwig et al 2004; von Rhein et al, 2009).                                 
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 OMVs from ClyA­expressing strains were found to contain oligomerised ClyA in its                       
active form, and this was dependent on the redox status of the OMVs, thus the activity of                                 
the toxin is specific to the vesicle environment (Wai et al, 2003).  A.                         
actinomycetemcomitans released OMVs containing 4­5 fold higher levels of biologically                   
active leukotoxin, LtxA, than detected in the bacterial membrane (Kato et al, 2002).  
 
OMV cargo can also restore function to parent cells. In  F. tularensis , mutations in a                             
lipase, FtlA, reduced its virulence  in vivo and ability to infect host cells. It was                             
subsequently found that FtlA is present in OMVs released from  F. tularensis , and                         
co­incubation of the mutant strain with the FtlA OMVs from the parent strain was able to                               
complement the loss of the gene, and restored its virulence and invasion of A549 cells                             
(Chen et al, 2017). 
 
The opportunistic human pathogen  Pseudomonas aeruginosa has been shown to produce                     
cytotoxic OMVs containing a variety of known virulence factors including the hemolytic                       
toxin Phospholipase C, and Cif, which inhibits the expression of the cystic fibrosis                         
transmembrane conductance regulator (CFTR) protein and enhances colonisation of  P.                   
aeruginosa in the cystic fibrosis lung (MacEachran et al 2007; Bomberger et al, 2009).                           
Cif delivered via OMVs was 17,000 fold more effective at reducing CFTR levels than                           
purified Cif protein, indicating that OMVs not only secrete biologically active virulence                       
factors, but they are also delivered highly efficiently, representing an effective means of                         
facilitating bacterial colonisation and pathogenesis (Bomberger et al, 2009). The secreted                     
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 and OMV­associated proteomes of  L. pneumophila were analysed, and of 25 known                       
virulence factors, 18 were found associated with OMVs, including 8 which were only                         
detected in the vesicle fractions (Galka et al, 2008).  
 
In contrast, the vacuolating toxin, VacA, in  H. pylori , can also be secreted as free toxin or                                 
OMV­associated, but in this case only 25% of toxin was exported via OMVs, and was                             
found to have reduced vacuolating activity in host cells compared with the freely secreted                           
form (Ricci et al, 2005). However, OMVs from  H. pylori are associated with other                           
cytotoxic effects, including increased genetic mutations, which may suggest a role for                       
OMVs in carcinogenesis associated with  H. pylori  (Chitcholtan et al, 2008). The                       
causative agent of whooping cough,  Bordetella pertussis , expresses an adenylate cyclase                     
toxin, ACT. Only around 1% of the total secreted ACT is OMV associated, but it was                               
found to enter host cells via a different mechanism to freely secreted ACT, using actin                             
microfilaments instead of the CD11b/CD18 receptors (Donato et al, 2012). OMVs are                       




OMVs also contribute to the formation and maintenance of biofilms. Biofilms are                       
aggregations of bacteria, which often form under stressful growth conditions, such as in                         
the presence of antibiotics, and are implicated in chronic and persistent infections that are                           
more resistant to treatment (Wang et al, 2015). Extracellular DNA is a known structural                           
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 component of  H. pylori biofilms, but is not susceptible to DNAse treatment, due to its                             
association with OMVs (Grande et al, 2015). A correlation between OMV release and                         
biofilm production was observed in a strain of  H. pylori that produced strong biofilms,                           
and transfer of these OMVs to other strains resulted in their enhanced biofilm formation                           
(Yonezawa et al, 2009). OMVs from  P. aeruginosa were found to have different size                           
distributions and protein composition when isolated from biofilms compared to those                     
produced during planktonic growth, suggesting that OMVs play different roles depending                     
on the lifestyle of the bacterial cells (Schooling and Beveridge, 2006).  
 
OMVs may contribute to the resistance of biofilms to treatment. OMVs isolated from a  P.                             
aeruginosa biofilm contained 34 different antibiotic resistance proteins, compared with                   
10 identified in OMVs from planktonic cultures (Park, Surette and Khursigara, 2014).                       
This is not just a reflection of the protein content of the cells of origin; one protein,                                 
penicillin binding protein 1B (mrcB) was not detected in the  P. aeruginosa cells isolated                           
from the biofilm, but was found at high levels in the OMVs. Another  P. aeruginosa                             
virulence factor, alkaline phosphatase, is involved in biofilm formation, and has also been                         
detected in OMVs (Bomberger et al, 2009). 
 
In  Porphyromonas gingivalis , a causative agent of dental plaques and chronic                     
periodontitis, a unique protein, HmuY, has been implicated in the secretion of the                         
extracellular matrix necessary for biofilm formation (Olczak et al, 2010). This protein is                         
also abundant in their OMVs, suggesting a role in the maintenance and accumulation of                           
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 biofilms. Dental plaques contain various bacterial species, and presence of OMVs has                       
been observed within these polymicrobial biofilms, containing Gram negative species                   
such as  P. gingivalis ,  Treponema denticola and  Tannerella forsythia , but additionally, the                       
isolated OMVs from  P. gingivalis have also been shown to cause aggregation of Gram                           
positive species, such as  Staphylococcus aureus , and fungal species such as  Candida                       






OMVs can also interact with the host immune system. Since they are derived from the                             
outer membrane, they contain lipopolysaccharide (LPS), which elicits potent immune                   
responses and release of pro­inflammatory cytokines via the binding of the Lipid A                         
portion of the LPS to the host cell TLR4 receptor (Kuehn and Kesty, 2005; Park et al,                                 
2010). A strain of  N. meningitidis which caused fatal septicemia was shown to be highly                             
vesiculating, and contributed to the fatally high levels of endotoxin in the patient                         
(Namork and Brandtzaeg, 2002). Inoculation with OMVs from  E. coli was sufficient to                         
cause lethal systemic inflammatory response syndrome (SIRS) in a mouse model, in the                         
absence of the bacterial cells (Park et al, 2010). Recognition of LPS by TLR4 requires                             
hexa­acylated Lipid A, and mutations in the  msbB gene prevents addition of the final acyl                             
chain, resulting in penta­acylated Lipid A.  msbB mutant OMVs showed a reduction in                         
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 endotoxicity and inflammatory responses compared with wildtype OMVs (Kim et al,                     
2009; Park et al, 2009; Rossi et al, 2014).  
 
Many OMV­associated toxins have been observed to have increased activity compared                     
with their freely secreted form. Similarly, in some cases OMVs were able to stimulate                           
inflammatory responses more effectively than the purified components alone. NadA, an                     
outer membrane adhesin of N. meningitidis  was found to bind and activate macrophages                          
and monocytes and cause cytokine release at 10 fold lower concentrations than required                         
for the free form of NadA (Tavano et al, 2009). In the study by Park et al (2010), OMVs                                     
induced lethal sepsis but when purified LPS was added at the same concentration as that                             
present in the vesicles, no sepsis was observed, even when the concentration of LPS                           
added was doubled (Park et al, 2010). These findings indicate that OMVs can contribute                           
to the stimulation immune responses, but this is not necessarily via LPS; LPS from  B.                             
abortus does not induce inflammation, and is considerably less endotoxic than LPS from                         
E. coli  (Kianmehr et al, 2015). 
 
Other components of the cell wall present in OMVs can also contribute to                         
immunogenicity. OMVs from  Aggregatibacter actinomycetemcomitans  entered host cells               
and delivered peptidoglycan, detected via intracellular NOD1 and NOD2 sensors and                     
induced activation of NFΚB (Thay et al, 2014), an effect also observed for OMVs from                             




Cytokine release in response to OMVs has been observed for a number of different                           
species, and both  in vitro and  in vivo . OMVs from  N. meningitidis triggered release of                             
TNFɑ, IL1β, IL8 and MIP1a and MIP1b by neutrophils, and also in a whole blood model                               
(Lapinet et al, 2000; Mirlashari et al, 2001), similarly to those of  N. gonorrhoeae which                             
induced secretion of IL6 and TNFɑ in macrophages (Makepeace et al, 2001).                       
Proinflammatory cytokine release has also been detected in non­immune cells, with                     
increased IL8 release observed for human intestinal and gastric cells when incubated with                         




OMVs can also have anti­inflammatory effects. Monocytes incubated with OMVs from                     
B. abortus showed reduced responses to LPS and flagellin, and subsequent infection with                         
live  B. abortus cells resulted in increased adhesion to and invasion of monocytes,                         
implying that OMVs can help to promote infection by interfering with the innate immune                           
response (Pollak et al, 2012).  
 
Ulcerative colitis and Crohn’s disease are chronic inflammatory diseases of the intestine.                       
E. coli  Nissle 1917 is a probiotic strain that is considered to be anti­inflammatory by                             
inhibiting the release of inflammatory cytokines and as a result, reduce the symptoms and                           
severity of ulcerative colitis (Losurdo et al, 2015; Fabrega et al, 2017). In a mouse model                               
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 of colitis, pre­treatment with OMVs from  E. coli Nissle showed less weight loss, lower                           
production of inflammatory markers, and less damage to the colon than observed in the                           
control mice (Fabrega et al, 2017). Other studies have found  E. coli Nissle to be as                               
effective in inducing remission from colitis as the current recommended treatment                     
mesalazine, and this work suggests that it may be the OMVs produced by this strain that                               
have an important role as anti­inflammatory mediators (Losurdo et al, 2015; Fabrega et                         
al, 2017).  
 
The commensal species,  Bacteroides fragilis , secretes OMVs carrying capsular                 
polysaccharide polysialic acid (PSA). PSA from the OMVs was able to bind dendritic                         
cells via TLR2, and resulted in increased numbers of T regulatory cells and a suppression                             
of pro­inflammatory cytokine release, indicating a mechanism for non­pathogenic species                   
to avoid triggering immune responses (Shen et al, 2012).  
 
The immunomodulatory effects of OMVs can also benefit other bacterial species. OMVs                       
from  M. catarrhalis containing ubiquitous surface proteins UspA1/A2 were able to bind                       
C3 of the complement system and prevented the complement cascade directed against  H.                         
influenzae , and promoted its survival (Tan et al, 2007).  
 
OMVs from  P. gingivalis carrying the cysteine proteases known as gingipains were                       
shown to cleave the LPS co­receptor CD14 from the cell surface of macrophages, which                           
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 resulted in a suppressed TNF­a response to subsequent addition of purified  E. coli LPS,                           
and may represent a means of immune evasion (Duncan et al, 2004).  
 
OMVs can also affect the adaptive immune system. OMVs from  H. pylori  induced                         
apoptosis of T cells, independently of the presence of the VacA toxin, and thus                           
suppressed T­cell mediated immune responses to infection (Winter et al, 2014).                     
Interferon­ɣ stimulated endothelial cells present antigens to CD4+ T cells via the surface                         
display of major histocompatibility complex (MHC Class II). After infection with  P.                       
gingivalis OMVs, IFN­ɣ signalling was inhibited which prevented the expression of the                       
MHC II genes and the display of antigens, and therefore the T­cell response was not                             
initiated (Srisatjalik et al, 2002). The Opa surface proteins of  N. meningitidis are known                           
virulence factors and are found in OMVs. Opa from  N. meningitidis OMVs was able to                             
bind human carcinoembryonic antigen­related cell adhesion molecule (CEACAM1) and                 
inhibit the activation and proliferation of CD4+ T cells (Lee et al, 2007). These studies all                               





The ability of OMVs to elicit immune responses can also be advantageous for the host.                             
OMVs from  S. enterica Typhimurium were able to induce maturation of dendritic cells                         
and activation of macrophages, and OMV­vaccinated mice were resistant to disease when                       
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 inoculated with live  Salmonella cells due to the production of antibodies and CD4+ T cell                             
responses (Alaniz et al, 2007). This indicated that the OMVs were able to generate both                             
innate and adaptive immune responses and protected the host from subsequent infection.                       
OMVs from the fish pathogen  Francisella noatunensis protected zebrafish from a high                       
dose inoculation of the live bacteria (Brudal et al, 2015).  
 
OMVs have been investigated as vaccine candidates due to their immunogenicity and                       
their relative safety as non­replicating antigens (Price et al, 2016). Their small size                         
facilitates access to tissues and lymphatic vessels, and they are stable when stored for                           
long periods of time (van der Pol, Stork and van der Ley, 2015). However, their use also                                 
presents significant challenges; the toxicity of their LPS, and the heterogeneity of their                         
cargo which may not elicit a sufficiently strong and specific immune reaction (van der                           
Pol, Stork and van der Ley, 2015). Several OMV­based vaccines have been developed                         
against  N. meningitidis , which typically use detergent extraction of OMVs to detoxify                       
their LPS, and these vaccines have shown high efficacy against the specific strain used in                             
the vaccine preparation but are often not cross­protective. A newer OMV vaccine,                       
Bexsero, has been developed to also incorporate recombinant antigens and provide more                       
immune coverage against other  N. meningitidis serogroups (Acevedo et al, 2014).  
 
B. parapertussis is a close relative of  B. pertussis , and also causes whooping cough                           
although its prevalence has been underestimated. Current vaccines against  B. pertussis                     
are not effective against  B. parapertussis ; in contrast, OMVs from  B. parapertussis were                         
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 protective against both species in a mouse model, and were also effective when                         
administered in the typical combination with tetanus and diphtheria antigens (Bottero et                       
al, 2013). Burkholderia pseudomallei  is the causative agent of melioidosis, a significant                        
public health problem in South East Asia and Northern Australia, where it is endemic,                           
and associated with high levels of morbidity and an estimated 42% mortality rate (Nieves                           
et al, 2014). Several virulent strains are co­endemic, and there is currently no vaccine and                             
little antibiotic susceptibility. OMVs from a clinical isolate of  B. pseudomallei were                       
protective against sepsis after challenge with live bacteria from the same strain, but also                           
against other clinical isolates (Nieves et al, 2014). OMVs may therefore be more broadly                           
antigenic and protective than currently used vaccines, and this could be exploited further                         
against infectious diseases for which there is no vaccine available. 
 
Engineering of OMVs to reduce their endotoxicity but enhance their expression of                       
specific relevant antigens has been explored. OMVs from EHEC O157:H7 with a                       
mutation in the  msbB gene to reduce the endotoxicity of the LPS have been used to                               
protect mice against hemolytic uremic syndrome (HUS) and also against a lethal dose of                           
WT O157:H7 OMVs (Choi et al, 2014). This mutation was also used in the                           
non­pathogenic  E. coli W3110, and the LPS­modified OMVs showed reduced                   
endotoxicity and stimulation of cytokine production, but caused comparable T­cell                   




 The protective immunity generated by OMVs can be expanded by the use of engineered                           
vesicles.  V. cholerae OMVs expressing PhoA from  E. coli were able to generate specific                           
PhoA antibody production in mice (Schild et al, 2009).  
 
OMVs can be used to deliver antigens from unrelated species.  S. enterica Typhimurium                         
OMVs were generated to incorporate the surface protein PspA from the Gram positive                         
pathogen  S. pneumoniae , and vaccination of mice with these modified OMVs protected                       
them from  S. pneumoniae infection, whilst no protection was conferred after inoculation                       
with purified PspA or empty vesicles (Muralinath et al, 2011).  Salmonella OMVs were                         
also used to display antigens from the intracellular pathogen  Mycobacterium tuberculosis ,                     
and the antigens were then presented via MHC II on dendritic cells to result in activation                               
of CD4+ T cells and initiate immune priming (Daleke­Schermerhorn et al, 2014).                       
Similarly,  E. coli OMVs were engineered to display the HtrA antigen from  Chlamydia                         
muridarum , resulting in antibody production and protection against Chlamydial infection                   
(Bartolini et al, 2013). Non­pathogenic  E. coli OMVs have been engineered to display                         
antigens from  C. jejuni and  S. pneumoniae to elicit production of antibodies in vivo                           
(Price et al, 2016).  
 
As well as forming the basis of the vaccine preparations, OMVs have also been                           
demonstrated to be useful adjuvants. Addition of OMVs to Protein D vaccination against                         
non­typeable  H. influenzae showed increased IgG production compared to Protein D                     
alone, and was comparable to the commonly used adjuvant alum (Behrouzi et al, 2016).                           
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 Mice vaccinated against  Salmonella showed a 6­40 times higher antibody titre when                       




Engineering of the cargo and surface of OMVs has been explored to broaden their                           
potential applications in immunotherapy and as anti­cancer treatments. An early study by                       
Kesty and Kuehn showed that fusion of GFP to the TAT signal sequence to allow its                               
accumulation in the periplasm enabled incorporation of GFP in the OMVs subsequently                       
isolated from non­pathogenic and pathogenic strains of  E. coli (Kesty and Kuehn, 2004).                         
The green fluorescent vesicles were also observed internalised in eukaryotic cells.                     
However, there is not a linear relationship between periplasmic protein concentration and                       
its concentration in OMVs (Alves et al, 2015). More recently, efforts have focused on                           
ways to develop a more homogenous population of engineered OMVs, and to increase                         
their overall yield. OMVs are cheap and quick to produce compared to the cost and                             
labour involved in expression and purification of other antigens required for vaccines                       
(Chen et al, 2010). Several genes have been identified which affect the amount of OMV                             
production, including  tolR,  a gene of the Tol­Pal system which is required by Gram                           
negative species for maintaining the integrity of the bacterial surface (Baker et al, 2014).                           
Mutations in  tolR result in a hypervesiculating phenotype, which has since been used for                           




ClyA is a cytolysin encoded by many strains of  E. coli , with homologs in  Shigella and                               
Salmonella  (Fahie et al, 2013). Despite containing no typical signal sequence for                       
secretion, ClyA is exported from the bacterial cell and causes cytotoxicity upon contact                         
with the mammalian cell membrane (Wai et al, 2003). Monomers of the 34kDa ClyA                           
protein accumulate in the periplasm, in an inactive oxidised state (Wai et al, 2003). ClyA                             
is exported into OMVs, where it becomes reduced, and forms an active oligomeric                         
complex that is embedded in the membrane (Roderer et al, 2016). This suggests the redox                             
conditions within the OMVs allow for the assembly and activity of ClyA, representing a                           
form of protein export that is independent of other secretion systems present in Gram                           
negative bacteria (Wai et al, 2003).  
 
Since ClyA is targeted into OMVs, its fusion with other molecules allows their export in                             
vesicles (Kim et al, 2008). ClyA­GFP fusions carried by OMVs elicited strong anti­GFP                         
antibodies, compared with inoculation with the fusion protein alone, indicating that                     
engineered OMVs can be used to generate immune responses to molecules that are                         
usually not strongly immunogenic (Chen et al, 2010).  
 
The ability of ClyA to localise in OMVs has also been investigated for treatment of                             
cancers. Fusion of ClyA to an affibody against Human Epidermal Growth Factor 2                         
(HER2), a membrane receptor that is overexpressed in 18­25% of breast and ovarian                         
cancers, allowed OMVs to target only cells expressing HER2 on the surface (Gujrati et                           
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 al, 2014). Furthermore, the ClyA­HER2 OMVs were loaded with siRNA against the                       
kinesin spindle protein, which is upregulated in cells undergoing rapid proliferation. The                       
engineered OMVs were able to target the HER2 expressing cells, and deliver siRNA,                         
resulting in apoptosis and the reduction of tumour growth in a mouse model (Gujrati et al,                               
2014). 
 
The glycan synthesis pathway has also been exploited for engineering of OMVs.                       
Insertion of plasmids containing the locus for synthesis of a complex carbohydrate from                         
pathogenic species such as  S. pneumoniae or  C. jejuni resulted in display of the glycan on                               
the surface of the OMVs, and induced specific antibody production in mice and chickens                           
respectively (Price et al, 2016). Glycan display is not just associated with infectious                         
disease; tumour cells often have altered expression of surface glycans. Expression of                       
Thomsen­Friedenrich antigen (T­antigen) on tumour cells is a hallmark of malignancy in                       
many common cancers such as breast and prostate (Valentine et al, 2016). Mice                         
immunised with OMVs engineered to display the T­antigen yielded high levels of                       




The potential uses for OMVs could be expanded if more was understood about the                           
biogenesis of OMVs. Whilst many genes have been implicated in their production, the                         
highly conserved and ubiquitous nature of OMV shedding across all Gram negative                       
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 species suggests there may be a conserved mechanism but this is as yet unidentified                           
(McBroom et al, 2006). Release of extracellular vesicles is not unique to Gram negatives,                           
or indeed to bacteria, as it is also observed for some Gram positive species and archaea,                               
and eukaryotic organisms (Lee et al, 2013; Gould et al, 2016).  
 
Several mechanisms for vesicle biogenesis have been proposed, and there is ongoing                       
debate surrounding these theories. There is evidence to support each of them, and whilst                           
it is possible there is a single conserved mechanism, it is also likely that there are several                                 
different pathways that all contribute to OMV production.  
 
Some theories have indicated a role of periplasmic peptidoglycan in enabling or directing                         
OMV release. Peptidoglycan forms a rigid inner layer beneath the outer membrane and                         
determines cell shape and holds its structure (Silhavy, Kahne and Walker, 2010). The                         
outer membrane is attached to the peptidoglycan layer by Lpp, a highly abundant protein                           
with around 500,000 molecules present in each cell (Silhavy, Kahne and Walker, 2010).                         
One theory has suggested that a reduction in the cross­linking of peptidoglycan to the                           
outer membrane allows the vesicles to pinch off from the cell surface, caused by the outer                               
membrane expanding faster than the periplasm, allowing areas of the OM to become                         
detached (Burdett and Murray, 1974; Hoekstra et al, 1976; Wensink and Witholt, 1981).                         
Mutations in genes implicated in cross­linking, such as lpp , result in hypervesiculating                       
phenotypes, supporting this theory (Bernadac et al, 1998). However, it does not account                         
for the constitutive and ubiquitous release of OMVs. 
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 Another theory suggests that it is not the reduced cross­linking of peptidoglycan that                         
causes OMV release, but instead the accumulation of peptidoglycan fragments in the                       
periplasm during cell growth exerts pressure on the cell wall, and release of OMVs                           
allows this pressure to be alleviated (Zhou et al, 1998). A mutation in  yfgl , a gene                               
involved in accumulation and turnover of peptidoglycan, resulted in a reduction in OMV                         
production, which was hypothesised to be due to reduced pressure on the cell wall                           
(Rolhion et al, 2005). Vesiculation is highest during log phase, which supports the theory                           
of OMVs being released as a consequence of cell growth and division (Hoekstra et al,                             
1976). However, it does not explain how cytosolic proteins are exported in the OMVs,                           
nor for the exclusion of some OM proteins (Jan, 2017).  
 
In contrast, it has been proposed that domains of the membrane that are enriched in                             
certain molecules allow ionic interactions that induce curvature of the membrane and                       
release of vesicles (Li et al, 1996; Nguyen et al, 2003). Specifically, the structure of the                               
lipopolysaccharide molecules on the outer membrane have been implicated in inducing                     
membrane curvature (Nguyen et al, 2003).  P. aeruginosa producing more B­band LPS                       
produced more OMVs, which is proposed to be due to the repulsion between the more                             
negatively charged B­band LPS molecules, compared with A­band LPS, which could                     
cause localised destabilisation of the membrane (Kadurugamuwa and Beveridge, 1995;                   
Sabra et al, 2003). Although this accounts for enrichment and exclusion of certain                         
molecules within OMVs, it does not explain production of OMVs in species with only                           
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 one form of LPS, or studies which show that OMV release is independent of membrane                             
instability (McBroom et al, 2006). 
 
The most recent mechanism that has been proposed has described a link between                         
phospholipid trafficking and OMV production, and is the first theory to propose a general                           
secretion mechanism that may be widely conserved and explain the ubiquity of OMV                         
production (Roier et al, 2016). The conserved VacJ/Yrb system is responsible for                       
maintaining the asymmetry of the OM by transporting phospholipids from the external                       
surface of the membrane to the inner leaflet (Malinverni and Silhavy, 2009). Disruption                         
within genes in this system resulted in increased vesiculation in the distantly related                         
species  H. influenzae ,  V. cholerae and  E. coli , whilst overexpression had the reverse                         
effect (Roier et al, 2016). The authors proposed that loss of retrograde phospholipid                         
transport caused accumulation of phospholipids in the outer leaflet of the OM, causing                         
membrane bulging and subsequent release of vesicles. Iron limitation is a common                       
stressor for bacteria, particularly within a host, and it was also shown that this transport                             
system was downregulated in response to iron starvation, and therefore increased                     
phospholipid accumulation and OMV release (Roier et al, 2016). Iron limitation may                       
trigger the production of OMVs during infection, helping the bacteria to exploit the broad                           




 These conflicting theories all help to explain certain aspects of OMV release, but it                           
remains to be identified whether there is a single universal process, or whether there are                             
several contributing mechanisms which vary depending on species, growth phase or                     
environmental conditions (Schwechheimer and Kuehn, 2015). 
 
Whilst much has been learnt about the biogenesis, secretion and cargo of vesicles in                           
recent years, there are still many areas left to explore. Their existence and function was                             
ignored for several decades, despite their ubiquity across Gram negative species and                       
beyond: it is likely that the scope of their role in bacterial interactions with the                             
environment is still underestimated. Understanding their true contributions to bacterial                   





Whilst many studies have identified the cargo delivered into host cells by OMVs, there is                             
still little agreement over how this delivery process occurs.  
Endocytosis is a process by which small molecules can cross the membrane bilayer of a                             
cell (Doherty and McMahon, 2009). In non­phagocytic cells, there are four main                       
pathways for the entry of small solutes: Macropinocytosis, clathrin mediated endocytosis,                     
caveolin mediated endocytosis, or non­caveolin, non clathrin mediated endocytosis                 
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 (Rewatkar et al, 2015). These pathways have all been implicated in mediating OMV                         
entry into host cells (Figure 1.1).  
 
OMV­mediated delivery of virulence factors occurs without requiring close proximity                   
between the bacterial cell and the host cell (Bomberger et al, 2009). The small size of                               
OMVs (20­200 nm) has made studying their interactions with host cells in real time                           
difficult. Previous work has often relied on OMVs labelled with dyes such as fluorescein                           
isothiocyanate (FITC) or dioctadecyloxacarbocyanine perchlorate (DiO). FITC labelling               
of OMVs from Enterotoxigenic  E. coli (ETEC) revealed delivery of heat labile                       
enterotoxin (LT) into host cells via lipid raft mediated endocytosis (Kesty and Kuehn,                         
2004). While such dyes allow real time study of OMV entry and cargo delivery                           
processes, the use of membrane labelling of the vesicles may interfere with their                         
physiological characteristics, and obscure the natural mechanisms of OMV entry and                     








Several different pathways allowing OMVs from a variety of Gram negative species of                         
bacteria to enter host cells have been described. These routes can require clathrin coated                           
pits, formation of caveolae, and use of lipid rafts or direct membrane fusion. OMV entry                             
can be impaired by the use of inhibitors against components of these pathways:                         
chlorpromazine–inhibits clathrin coated pit formation; papain–proteolytically degrades             
surface protein receptors; monensin–ionophore, dissipates proton gradient;             
monodansylcadaverine–inhibits receptor internalization; dynasore–inhibits dynamin         
GTPase activity; methyl­β cyclodextrin–extracts cholesterol from membrane; filipin and                 
nystatin–intercalate and disrupt cholesterol­rich membrane domains;           
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Macropinocytosis, or ‘cell drinking’ is characterized by the formation of large (over 200                         
nm in diameter), actin­driven, ruffled protrusions from the cell membrane, which allow                       
the sampling and internalization of extracellular medium (Weiner et al, 2016). Its role in                           
infection has been observed for  S. flexneri , which invades host cells via macropinosomes                         
(Weiner et al, 2016). The pathway is also utilized by viruses, which are comparable in                             
size to OMVs (Mercer and Helenius, 2008). It has therefore been suggested that OMVs                           
can enter host cells via macropinocytosis (Kaparakis­Liaskos and Ferrero, 2015).                   
Inhibition of actin polymerization by cytochalasin D or wiskostatin has been observed to                         
reduce the entry of OMVs from  P. aeruginosa into airway epithelial cells (Bomberger et                           
al, 2009). However, macropinocytosis is generally not a cargo induced process, and it is                           
likely that entry via this route is not a deliberate OMV­driven event (Lim and Gleeson,                             
2011). Treatment with actin inhibitors is not entirely specific for macropinocytosis;                     
movement of endosomes also requires actin remodeling, and so reduced cargo delivery                       
after these treatments may also be due to the inadvertent effect on other endocytic routes                             
(Soldati and Schliwa, 2006).  
 
Macropinocytosis allows internalization of endocytic vesicles up to 1 um in diameter,                       
whereas clathrin dependent and caveolin or lipid raft mediated endocytosis generally                     
allows internalization of considerably smaller cargo (120 nm, 60 nm, and 90 nm                         
respectively; Amano et al, 2010). The size of OMVs ranges from 20 to 500 nm, and this                                 
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Clathrin mediated endocytosis occurs via the formation of clathrin coated pits up to 200                           
nm in diameter (Vercauteren et al, 2010). Unlike macropinocytosis, internalisation can be                       
triggered by ligand binding to cell surface receptors (Rewatkar et al, 2015). Budding off                           
of the vesicle requires dynamin, and the internalised vesicle enters the endosomal                       
trafficking routes, from where its cargo can be returned to the cell surface or targeted to                               
lysosomes for degradation (Ritter et al, 1995). Many bacterial virulence factors, such as                         
shiga toxin, cholera toxin and the arg­gingipain adhesin of  P. gingivalis  have been shown                           
to utilise clathrin mediated endocytosis to gain entry into host cells during infection                         
(Sandvig and van Deurs, 2002; Boisvert and Duncan, 2008). Since OMVs are known to                           
transport various virulence factors during infection, it is reasonable to infer that they can                           
utilise toxin­receptor interactions to facilitate their cargo delivery via clathrin dependent                     
endocytosis. Clathrin mediated endocytosis is typically inhibited using drugs such as                     
chlorpromazine to prevent formation of clathrin coated pits, or dynamin inhibitors to                       
prevent scission of the endosome from the membrane (Vercauteren et al, 2010). 
 
Several studies have identified clathrin mediated endocytosis as a route for OMV entry.                         
Vacuolating toxin VacA in  H. pylori is an important cytotoxic virulence factor that is                           
found in OMVs during infection (Parker et al, 2010). VacA containing OMVs entered                         
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 host cells more efficiently than their VacA deficient counterparts, in a cholesterol                       
independent fashion, but inhibition of clathrin mediated endocytosis by chlorpromazine                   
had a stronger inhibition on VacA deficient OMVs, suggesting that VacA is not a receptor                             
ligand but may enable the OMVs to adapt to use alternative pathways in the absence of                               
the clathrin mediated pathway (Parker et al, 2010). The OMVs were labelled with the                           
lipophilic dye DiO, and intracellular fluorescence was measured using flow cytometry. It                       
is not clear whether membrane labelling of OMVs affects their function or interaction                         
with the membranes of host cells, and the affinity of lipophilic dyes for plasma                           
membranes necessitates stringent controls and washing steps to ensure the dye does not                         
label the cell membrane in addition to the vesicle (Mulcahy et al, 2014).  Lipophilic dye                             
molecules have been extensively used due to their efficient incorporation into                     
membranes. However, the dye molecules can also form aggregates and enriched domains                       
resulting in changes to the mobility and stiffness of the lipid bilayer, and these physical                             
alterations may in turn affect the behavior of the labeled membrane (Lulevich et al,                           
2009). 
 
Contradictory findings to work from Parker et al. were presented by Kaparakis et al                           
(2010), who observed that entry of  H. pylori OMVs was dependent on lipid rafts, and                             
entry was significantly reduced after sequestration of cholesterol from the host cell                       
membrane.  A similar finding was also observed by Olofsson et al, which demonstrated a                           
role for lipid­raft associated cholesterol in entry of  H. pylori OMVs, which was inhibited                           
by treatment with methyl­β cyclodextrin or filipin (Olofsson et al, 2014).  OMV release is                           
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 a conserved phenomenon, but there are considerable differences in composition and                     
activity of OMVs between species, between strains, and even between the same strain                         
under different external pressures (McBroom and Kuehn, 2007). This may explain some                       
of the discrepancies in the data regarding the uptake routes of OMVs from the same                             
strains.  The study by Kaparakis et al used Alexa Fluor labeled OMVs, with antibody                           
labeling used to determine internalization and lipid raft stains to observe colocalization.                       
However, using light microscopy to observe OMVs can be problematic due to their small                           
size (often less than ~100 nm) and there is a need for a more reliable and high resolution                                   
method of quantifying and identifying internalization of OMVs, particularly when                   
attempting to assess colocalization of OMVs with particular compartments of the cell                       
(Mulcahy et al, 2014). Furthermore, antibody labeling may obscure OMV epitopes                     
important in determining association with host receptors and thus, entry mechanism.                     
Uptake of OMVs has been shown to be a rapid process, with internalization detected as                             
little as 15 min following infection (Wai et al, 2003). Many methods involving use of                             
immunofluorescence microscopy require fixation at pre­determined time points, and a                   
live cell imaging method would be beneficial to define the kinetics of OMV interactions                           
with host cells.  
 
Methods used to isolate OMVs can also vary, with most using ultracentrifugation but                         
others using sucrose gradients or commercially available isolation columns (Chutkan et                     
al, 2013). The size of the OMV population is relevant when studying endocytic routes;                           
clathrin mediated endocytosis generally allows internalisation of larger cargo than                   
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 clathrin­independent routes (El­Sayed and Harashima, 2010). Different isolation methods                 
can introduce a bias towards particular sizes of OMVs, for example with the use of filters                               
to exclude particles over 200 nm in diameter, or columns which allow retention of                           
smaller particles  and the lack of standardized isolation procedures may also explain some                         
of the differences in findings in studies of OMVs from the same species (Kulp and                             
Kuehn, 2010). 
 
Other evidence for the entry of OMVs via receptor mediated endocytosis was recently                         
described by Vanaja et al, (2016) who showed that in cells with an siRNA knockdown of                               
AP2, an adaptor protein required for internalization of clathrin coated pits, there was a                           
reduced response to the LPS delivered by EHEC OMVs. This indicated a reduction in the                             
ability of the OMVs to enter the cell, which was also observed when the LPS of the                                 
OMVs was neutralized with polymyxin B, suggesting a functional link between LPS,                       
clathrin and the induction of inflammatory responses (Vanaja et al, 2016). The fate of the                             
LPS was to escape the endosomal compartments and induce caspase­11 activity, causing                       
cytokine production and cell death. LPS can be a highly immunogenic component of                         
OMVs, (Vanaja et al, 2016) and modification of LPS has been used as a way to reduce                                 
immunogenicity and enhance the suitability of OMVs as an adjuvant in vaccine                       




 Caspase induction was also observed after incubation with enteroaggregative  E. coli                     
O104:H4 OMVs (Kunsmann et al, 2015). Labeled OMVs were found to contain several                         
antigens, including shiga toxin, flagellin and enterotoxin, and caused cell death by the                         
induction of caspase­9 mediated apoptosis, and inflammation through increased IL­8                   
release (Kunsmann et al, 2015). Treatment with dynasore and chlorpromazine                   
significantly reduced the uptake of OMVs, suggesting entry of OMVs and their cargo                         
occurs via the receptor mediated endocytic pathway (Kunsmann et al, 2015).                     
Neutralization of OMV LPS with polymyxin B reduced the secretion of IL­8, in                         
agreement with other studies indicating a role of LPS in driving pro­inflammatory                       
responses (Kunsmann et al, 2015; Vanaja et al, 2016). 
 
OMVs from EHEC containing the hemolysin HlyA were shown to enter host cells, with                           
HlyA released from lysosomes into the cytoplasm where it was then trafficked to                         
mitochondria, resulting in caspase­3 and caspase­9 activation and subsequent death of                     
epithelial and endothelial cells (Bielaszewska et al, 2013). Treatment with dynasore and                       
chlorpromazine significantly reduced OMV entry, suggesting EHEC­HlyA OMVs enter                 
via clathrin mediated endocytosis. Fluorescence microscopy confirmed the colocalization                 
of HlyA and clathrin, while there was no colocalization observed between HlyA and                         
caveolin (Bielaszewska et al, 2013). When free HlyA was added to the cells, it remained                             




 Many studies have demonstrated a role for clathrin in the internalization of OMVs, but                           
with the caveat that OMVs are able to compensate well in the absence of this entry route.                                 
Similarly to the finding by Parker et al that OMVs can utilize more than one route of                                 
entry, OMVs from  A. actinomycetemcomitans showed a 25% reduction in uptake when                       
clathrin mediated endocytosis was inhibited by monensin, and an equivalent reduction                     
when cholesterol was bound by filipin (Parker et al, 2010; Thay et al, 2014). OMVs from                               
B. abortus were also shown to enter monocytes primarily via a clathrin dependent route,                           
with monodansylcadaverine treatment resulting in a 33% inhibition of OMV entry, and                       
no effect seen after filipin treatment (Pollak et al, 2012). However, the partial level of                             
inhibition implies that the OMVs are able to use alternative pathways. Interestingly, the                         
study also showed that pre­incubation with OMVs prior to infection with whole cells                         
inhibited the TNF responses, and increased the numbers of internalized  B. abortus ,                       
demonstrating a role for OMVs in immunomodulation during or prior to subsequent                       
infection. The ability of toll­like receptors to activate upon addition of their agonists was                           
also reduced after pre­treatment with OMVs (Pollak et al, 2012). This study was                         
conducted with monocytes rather than epithelial cells and there may be differences in                         
entry of OMVs into phagocytic cells compared with non­phagocytic cell lines used in                         
many studies (Pollak et al, 2012). 
 
Incomplete levels of inhibition were also seen in studies with  H. pylori  OMVs, with a                             
method termed ‘Quantification of internalised substances’ which labeled the  H. pylori                     
OMVs with a dye containing a cleavable disulphide bond, allowing quenching of                       
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 extracellular OMV­associated fluorescence by the addition of a reducing agent (Olofsson                     
et al, 2014). Fluorescence inside the epithelial cells was then assessed with microscopy                         
(Olofsson et al, 2014). This work demonstrated involvement of dynamin, with dynamin                       
inhibition causing an 80% reduction in internalization, but chlorpromazine only reducing                     
internalization by 40% (Olofsson et al, 2014). Dynamin is involved in both clathrin                         
mediated and caveolin mediated endocytosis, and so it appears that there is a contribution                           
of both clathrin mediated and caveolin mediated endocytosis towards OMV entry                     
(Vercauteren et al, 2010). 
 
Entry into a cell via the clathrin mediated endocytic pathway typically utilizes                       
receptor­ligand binding to drive internalization (El­Sayed and Harashima, 2013). While                   
this route has been implicated in many studies of OMV entry, the possible ligands have                             
remained elusive. If internalization of OMVs requires these interactions, then identifying                     




Many studies have indicated a role for lipid rafts in enabling OMV entry (Furuta et al,                               
2009; Kaparakis et al, 2010; Jin et al, 2011; Schaar et al, 2011; Sharpe, Kuehn, and                               
Mason, 2011; Elmi et al, 2012; Kim et al, 2010; Thay et al, 2014; Mondal et al, 2016) .                                     
Lipid rafts are domains of the plasma membrane that are enriched in sphingolipids and                           
cholesterol (Mulcahy et al, 2014). The lipid composition of these domains causes them to                           
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 be more ordered and compact than neighboring regions (Simons and Ehehalt, 2002).                       
Cholesterol­rich regions are abundant in the bilayer, and it is hypothesized that clustering                         
of the regions allows curvature of the membrane, driving formation of invaginations in                         
the host cell and entry of particles into the cell (Pelkmans, 2005). It is well­established                             
that viruses exploit lipid rafts to enter host cells and the similarities between enveloped                           
viruses and OMVs in terms of size and composition would suggest a potential affinity for                             
this route of entry (Kulp and Kuehn, 2010). 
 
Cholesterol is a principal component of lipid raft domains, and cholesterol dependency                       
has been demonstrated for entry of OMVs from a variety of species (Bomberger et al,                             
2009; Furuta et al, 2009; Kim et al, 2010; Jin et al, 2011; Schaar et al, 2011; Sharpe et al,                                       
2011; Elmi et al, 2012; Olofsson et al, 2014; Thay et al, 2014; Mondal et al, 2016).                                 
Cholesterol­rich microdomains are commonly disrupted by using chemicals such as                   
methyl­β­cyclodextrin (mbcd, sequesters and depletes cholesterol from the cell                 
membrane) or filipin (binds to cholesterol in the membrane and disrupts lipid packing,                         
Danthi and Chow, 2004; Vercauteren et al, 2010; Maxfield and Wustner, 2012).  
 
Many reports have used this approach to demonstrate the importance of membrane                       
cholesterol for delivery of OMV cargo. OMVs from  Vibrio vulnificus delivered                     
cytolysins into epithelial cells to induce cell death, but this effect was diminished in the                             
presence of filipin (Kim et al, 2010). Treatment with mbcd prevented delivery of OmpA                           
from  A. baumannii  OMVs to host cells (Jin et al, 2011). OMVs commonly cause immune                             
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 activation via the induction of cytokines, and their production is measured using ELISAs                         
to determine the level of inflammatory stimulation (Schaar et al, 2011; Sharpe et al, 2011;                             
Elmi et al, 2012; Pollak et al, 2012; Kunsmann et al, 2015; Mondal et al, 2016; Waller et                                   
al, 2016). Treatment of host cells with mbcd prior to infection with OMVs from                           
Campylobacter jejuni  resulted in reduced production of IL­8, IL­6 and TNF­α (Elmi et al,                           
2012). The cargo of OMVs can also assist in allowing lipid­raft mediated entry processes.                           
OMVs from a clinical isolate of  P. aeruginosa displayed PaAP aminopeptidase on the                         
surface and showed a 40% higher association with lung cells than the OMVs from a                             




Lipid raft domains can also be enriched in caveolin, and the oligomerization of caveolin                           
allows formation of caveolae (Rewatkar et al, 2015). Caveolae are cave­shaped                     
invaginations that are formed on the cell membrane, around 80 nm in diameter, and                           
enriched in cholesterol, caveolins, and sphingolipids (Mulcahy et al, 2014). Similarly to                       
clathrin mediated endocytosis, dynamin is also required for scission and internalization of                       
caveolae (Rewatkar et al, 2015). Although the speed of caveolae internalization is around                         




 Interactions between pathogens and caveolae have been reported, and caveolae have been                       
suggested as a preferential invasion mechanism for many pathogens, including bacteria,                     
viruses and fungi, as the internalised caveolae are thought to avoid fusion with lysosomal                           
compartments and subsequent degradation, in contrast to clathrin coated pits (Anderson,                     
Chen, and Norkin, 1996; Long et al, 2012; Lim et al, 2014).  E. coli and  Leishmania                               
chagasi internalized via caveolae are able to persist within macrophages (Baorto et al,                         
1997; Rodriguez, Gaur, and Wilson, 2006). Chlamydial species are able to avoid                       
detection during intracellular infection by using caveolins to disguise the internalized                     
phagosome as a host­derived vesicle (Norkin, Wolfrom, and Stuart, 2001). Simian virus                       
40 (SV40) also enters host cells through caveolae, and uptake of exosomes produced                         
from cells infected with Epstein Barr virus also requires caveolae (Anderson et al, 1996;                           
Nanbo, Kawanishi, Yoshida, and Yoshiyama, 2013). 
 
There are now numerous examples of OMVs utilizing caveolin mediated endocytosis to                       
enter host cells. However, many studies often fail to distinguish between lipid raft                         
dependency, which is inhibited by cholesterol depletion, and caveolin­specific lipid raft                     
dependency, which is sensitive to both cholesterol and dynamin depletion. OMVs from                       
non­typeable  Haemophilus influenzae were shown to enter and colocalize with caveolin 1                       
(Cav­1), a marker of caveolae, by western blotting of epithelial cell lysates after infection                           
(Sharpe et al, 2011). Treatment of cells with filipin to disrupt cholesterol rich                         
microdomains in the membrane abolished this interaction. The same study showed that                       
while binding of OMVs to the cell membrane could occur at 4 °C, internalization only                             
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 occurred after incubation at 37 °C. This is in agreement with work by Kesty et al. (2004)                                 
which showed reduced entry of ETEC OMVs into HT29 intestinal epithelial cells at 4 °C                             
compared with 37 °C, and also by Jager et al. (2014) which demonstrated the temperature                             
dependence of uptake for OMVs from  Legionella pneumophila , suggesting that OMV                     
entry is not a passive process. 
 
Caveolin mediated endocytosis of OMVs has been found in many cases to utilize                         
interactions between bacterial ligands and host cell receptors. OMVs from  M. catarrhalis                       
entered human epithelial cells via interactions between toll­like receptor 2 (TLR2) and                       
lipid rafts (Schaar et al, 2011). Internalization of FITC­labeled OMVs was not observed                         
after treatment with filipin, suggesting that the receptors were localized in                     
cholesterol­rich regions of the membrane. Cholera toxin (CTx) is a virulence factor of  V.                           
cholerae known to bind to the ganglioside GM1 present in caveolin enriched lipid rafts                           
on the host cell surface, and is secreted in both soluble and OMV­associated forms                           
(Chatterjee and Chaudhuri, 2011). During infection of intestinal epithelial cells,                   
OMV­associated CTx was shown to rapidly target GM1 after only 15 min and facilitate                           
internalization of the OMVs (Chatterjee and Chaudhuri, 2011).  
 
Similarly, entry of ETEC OMVs relied on the association of heat labile toxin (LT)                           
contained within the OMV membrane with the toxin receptor, and immunofluorescence                     
microscopy revealed colocalization of labeled caveolin and vesicles (Kesty et al, 2004).                       
OMVs derived from an LT deficient strain showed a 60% lower association with host                           
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 cells, demonstrating the role of specific OMV cargo in driving uptake processes.                       




Alternatively, lipid raft mediated endocytosis can be independent of caveolin and                     
dynamin and instead require small GTPases (Rewatkar et al, 2015). These GTPase                       
dependent processes are the least well characterized of endocytic routes, but are generally                         
defined as uptake into the cell via uncoated membrane invaginations (Mayor, Parton, and                         
Donaldson, 2014). 
 
OMV­associated proteases from  V. cholerae reportedly were delivered into intestinal                   
epithelial cells via this dynamin independent, lipid raft mediated endocytic route (Mondal                       
et al, 2016). Induction of pro­inflammatory cytokines following infection with OMVs                     
was measured using ELISA, and cytotoxicity determined using flow cytometry. Both                     
responses were reduced after treatment with mbcd to deplete cholesterol, but no effect                         
was observed after dynamin inhibition (Mondal et al, 2016).  
 
The oral pathogen  P. gingivalis secretes OMVs containing virulence factors such as                       
gingipains and fimbriae, and these OMVs were shown to enter HeLa and gingival                         
epithelial cells in a Rac1/lipid raft dependent manner, and independent of caveolin,                       
clathrin, and dynamin (Furuta et al, 2009). Interestingly, these OMVs were rapidly                       
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 directed to lysosomes, but avoided degradation for over 24 hr following entry (Furuta et                           
al, 2009). Despite being unable to deliver their contents into the cytosol, the strong and                             
prolonged acidification of lysosomes induced by the OMVs caused cellular damage, even                       
without delivery of specific virulence factors (Furuta et al, 2009). 
 
OMVs can also influence host cellular responses without entering cells. When all                       
endocytic routes were inhibited, OMVs from  P. gingivalis were still able to cause                         
suppression of immune signaling and increase tolerance to subsequent infection through                     
the induction of TLR4 on the cell surface of monocytes (Waller et al, 2016). In some                               
cases, OMVs can even cause effects in host cells distal from the initial site of infection                               
and OMV production. OMVs from  S. enterica were produced by whole bacteria in the                           
Salmonella containing vacuole (SCV) and the vesicles were able to escape not just the                           
SCV but the infected host cell, and enter uninfected neighboring cells to deliver the                           




Despite the different architecture of the membrane bilayer present in OMVs and that of                           
host eukaryotic cells, membrane fusion has been described as a mechanism for OMV                         
entry into host cells. The self­quenching fluorescent dye Rhodamine­R18 was used to                       
label OMVs from  P. aeruginosa (Bomberger et al, 2009). When added to host epithelial                           
cells, an increase in fluorescence was observed due to lipid mixing between vesicle and                           
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 host membrane bilayer, leading to dilution and de­quenching of the dye. The increase in                           
fluorescence was used as a quantitative determinant of membrane fusion between the                       
OMV and the cell membrane (Bomberger et al, 2009). Lipid rafts were labeled with                           
CTxB subunit, and there was colocalization between sites of membrane fusion and the                         
labeled lipid rafts, and the fusion events were inhibited in the presence of filipin. This                             
indicated that membrane fusion events preferentially occur at lipid raft domains                     
(Bomberger et al, 2009). A similar technique was used to assess membrane fusion                         
between OMVs from  A. actinomycetemcomitans and HeLa cells, which utilized confocal                     
microscopy to identify colocalization between the toxin component cytolethal distending                   
toxin (CDT) and the labeled lipid rafts and sites of dequenched membrane labeling                         
(Rompikuntal et al, 2012). A caveat of studies employing mbcd and filipin to deduce the                             
involvement of lipid rafts in OMV uptake is that both agents, by disrupting a major                             
constituent of the membrane, affect membrane organization on a large scale and may                         
have effects on processes not limited to lipid rafts. 
 
Model membranes have been utilized to confirm that membrane fusion can occur                       
between OMVs and host cell membranes, despite their structural differences.                   
Phospholipid liposomes mimicking host cell membranes were labeled with a pair of                       
FRET dyes to demonstrate that OMV membrane material from  L. monocytogenes can be                         
included into the model host bilayer, by monitoring the change in FRET signal, which                           
increased upon incorporation of OMV membrane due to an increase in surface area                         
(Jager et al, 2014). The fusion events occurred just seconds after addition of OMVs,                           
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 highlighting the rapid and efficient kinetics behind OMV interactions with host cells                       
(Jager et al, 2014). The interaction was also observed to be partially temperature                         
dependent, with a lower level of incorporation when the experiment was conducted at 4                           
°C compared to 37 °C, but there was still a notable level of membrane fusion detected,                               
suggesting that fusion does not entirely depend on active, energetic processes (Jager et al,                           
2014). 
 
There are considerable discrepancies between findings determining OMV entry routes                   
into host cells. Differences in uptake routes between OMVs from different species may                         
well be explained by the fact that OMV composition is adapted to direct vesicles towards                             
a specific uptake route, and thus allow them to undergo ideal processing within the host                             
cell to facilitate infection. However, discrepancies also exist between studies analyzing                     
entry of OMVs from the same species. This may be due to variation in methodologies,                             
such as the isolation and quantification of OMVs, the labeling or imaging techniques, or                           
the strains, host cell types and cell lines used. It is also apparent that OMVs can use                                 
multiple routes to enter host cells.  
 
Different isolation techniques result in different levels of purity and/or size distributions                       
of the OMV preparations. Quantification of OMVs used for uptake assays also varies                         
between studies, and particularly the use of total protein contained within the OMV                         
preparation as a means of normalization is problematic, as protein content and                       
composition can vary widely between OMV preparations derived under different growth                     
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 conditions (McBroom and Kuehn, 2007). Despite these challenges, the existing literature                     
clearly demonstrates that OMVs are well adapted to direct and deliver their cargo into                           
host cells. In order to fully elucidate the mechanisms underpinning these processes, it is                           
necessary to develop a consistent, quantifiable and dynamic approach to measure OMV                       
association, entry and cargo delivery to host cells. 
 
Deepening our understanding of how the structure of the vesicle surface can direct OMVs                           
towards a specific uptake route, and thus, determine the fate of vesicular contents within                           
the host cell is essential and will allow the future exploitation of OMVs for medical                             
applications (Berleman et al, 2013). OMVs engineered to display a ClyA­HER2 targeting                       
probe were able to target cells over­expressing HER2, a common biomarker of cancer                         
cells, and induce cell death and tumor shrinkage via the delivery of siRNA targeting the                             
expression of kinesin spindle protein (Gujrati et al, 2014). Insights on OMV entry would                           
allow production of engineered OMVs with high affinity for specific cell types or tissue                           






Exploring the interactions between OMVs and host cells requires an appreciation of their                         
origin from the bacterial cell envelope. Bacteria experience a wide range of challenging                         
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 and dynamic environmental conditions, and are able to survive and adapt in part due to                             
their sophisticated cell envelope (Silhavy, Kahne and Walker, 2010). The unique and                       
complex structure allows for compartmentalisation of the cytoplasm and confers                   
protection and resistance to hostile environmental conditions, such as heat, acid and the                         
presence of antibiotics (Ruiz, Kahne and Silhavy, 2006). Cell envelope synthesis and                       
maintenance requires a significant energy contribution by the bacterial cell; a fifth of the                           
E. coli genome is dedicated to the cell envelope, an indication of its vital role in                               




The cell envelope of the Gram negative model organism  E. coli  consists of 3 layers. The                               
inner membrane is a typical phospholipid bilayer that forms a fluid boundary between the                           
cytoplasm and the cell wall. In  E. coli , it is around 5.5 nm thick and is composed                                 
primarily of three phospholipid species: Phosphatidylethanolamine, phosphatidylglycerol,             
and cardiolipin (Weiner and Rothery, 2007). It allows protection and separation of                       
cytosolic contents. Due to the absence of organelles in bacteria, many cellular functions,                         
such as lipid and peptidoglycan synthesis, active transport and cell division are performed                         
at the inner membrane. It therefore contains a diverse range and high concentration of                           





External to the inner membrane is a viscous section known as the periplasm (Goemans et                             
al, 2014). It is enriched in proteins, and segregation of these proteins, such as nucleases                             
and proteases, in the periplasmic layer allows their functions to be performed away from                           
the cytoplasm and prevent cell damage, analogous to lysosomes in eukaryotic cells                       
(Weiner and Li, 2008; Silhavy et al, 2010). The periplasm is estimated to comprise                           
20­30% of the total cell volume, occupying around 50 nm (van Wielink and Duine,                           
1990). Within the periplasm is a layer of peptidoglycan, a polymer consisting of repeating                           
units of the disaccharide N­acetylglucosamine­N­acetyl muramic acid (Vollmer et al,                   
2008). Peptidoglycan helps to maintain cell rigidity and shape, and is involved in cell                           
growth and division. Its essentiality to bacteria has been exploited through the use of                           
β­lactam antibiotics which inhibit the formation of peptidoglycan cross linkages and lead                       
to cell lysis (Kohanski et al, 2010). The thin layer of peptidoglycan in Gram negative                             




Anchored to the peptidoglycan in the periplasm is the second, outer­most membrane, that                         
is absent in Gram positive bacteria. This membrane forms a considerable, selective                       
barrier that is the interface between the bacterial cell and its environment. Its integrity is                             
crucial for survival. Use of antibiotics against Gram negative species of bacteria require                         
the ability to permeate the outer membrane (Delcour, 2009). Some antibiotics, such as                         
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 vancomycin, are ineffective against Gram negatives as they cannot traverse this barrier                       
(Miller, 2010). Unlike the inner membrane, this is not a typical membrane bilayer. The                           
outer membrane is asymmetrical, with phospholipids comprising the inner leaflet, but the                       
outer leaflet is composed of lipopolysaccharide (LPS). It contains fewer proteins than the                         
other layers of the envelope, and these proteins are typically either trans­membrane                       
anti­parallel β­barrel structures, (known as OMPs) in contrast to the ɑ­helices found in                         
the inner membrane, or lipoproteins (Weiner and Li, 2007). Unlike in the inner                         
membrane, there is no proton motive force available to drive substrate transport across                         
the OM and instead these highly expressed β­barrels form channels known as porins                         
which allow the free movement of small (<600 Da) hydrophilic molecules through the                         
outer membrane (Bos et al, 2007; Miller, 2016). Cells which down regulate expression of                           




At the outer surface of the bilayer is lipopolysaccharide (LPS). This molecule consists of                           
3 main regions, from inside to out: Lipid A, core, and O polysaccharide. Forming the top                               
of the outer membrane bilayer is Lipid A, a glucosamine disaccharide with 6 or 7 acyl                               
chains, which is attached to the polysaccharide core region which, in turn, is linked to the                               





Lipid A is synthesised by 9 enzymes, and its formation occurs in the cytoplasm and the                               
inner membrane (Wang and Quinn, 2010). LpxA, C, and D convert UDP­GlcNAc into                         
UDP­diacyl­GlcN by the addition of two fatty acid chains. This is then hydrolysed,                         
condensed and phosphorylated by LpxH and LpxB, before phosphorylation by LpxK.                     
The KdtA enzyme then adds Kdo (deoxy­D­manno­oct­2­ulosonic acid) residues. The                   
final two steps result in the addition of a lauryl and myristoyl residue to the final                               
glucosamine residue by LpxL and LpxM acyltransferases (Raetz et al, 2007). MsbA is an                           
essential ABC transporter that is required to transfer newly synthesised Lipid A from the                           
inner membrane to the outer membrane; in its absence, LPS accumulates at the inner                           
membrane (Zhou et al, 1998).  
 
Lipid A is a highly abundant molecule, and although the majority of species are not                             
viable without Lipid A or LPS, its absence can confer advantages. Spontaneous loss of                           
genes required for LPS and Lipid A biosynthesis in  A. baumannii allow resistance to                           
colistin, an antibiotic which targets Lipid A (Henry et al, 2012). Lipid A is a potent                               
innate immune activator in mammalian cells, specifically macrophages (Raetz and                   
Whitfield, 2002). Innate immunity is triggered by the presence of pathogen­associated                     
molecular patterns (PAMPs) which are recognised by pattern recognition receptors                   
(PRRs) (Lizundia et al, 2008). In the case of LPS, this occurs via the recognition of the                                 
acyl chains by Toll­like Receptor 4 on the cell surface (Akira et al, 2006). LPS is bound                                 
by the LPS binding protein, LBP, which converts LPS into monomers that can in turn                             
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 associate with CD14 on the cell membrane (Miller et al, 2005). Lipid A is then                             
transferred to MD2­TLR4 at the extracellular surface and oligomerises to recruit signal                       
transduction adaptor proteins via the TIR (Toll Interleukin­1 Receptor) domain of TLR4.                       
Signal transduction is either MyD88­adaptor dependent or independent, resulting in                   
release of pro­inflammatory cytokines, or maturation and activation of adaptive immune                     
cells (Kawai et al, 2001; Akira et al, 2006; Lu et al, 2008; Needham and Trent, 2013). 
 
Recognition of Lipid A by macrophages results in the release of pro­inflammatory                       
modulators such as TNFɑ and IL1β, and in turn activates the adaptive immune response                           
in order to control the infection (Rietschel et al, 1994). Regulation of these responses is                             
linked to other diseases; severity of asthma is positively correlated with the concentration                         
of LPS in house dust (Michel et al, 1996). A strong and uncontrolled over­induction of                             
these responses can lead to septic shock, organ failure and mortality (van Deuren, 2000).  
 
Sepsis is a severe complication of infection, and over half of cases occur in the context of                                 
a Gram negative bacterial infection (Wenzl, 1992). A single nucleotide polymorphism                     
from aspartic acid to glycine at residue 299 of the TLR4 gene is a relatively common                               
genotype, (~10­20% of the population) that results in changes to the extracellular domain                         
of the receptor and is associated with a reduced response to LPS, increased number of                             
infections, and a subsequent defect in clearing infection (Arbour et al, 2000; Agnese et al,                             
2002). Although this mutation resulted in a reduced localised response to LPS,                       
surprisingly it was also found exclusively in patients with septic shock and was absent in                             
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 the healthy controls, suggesting a fine balance between the induction of the TLR4                         
response and the control of infection (Lorenz et al, 2002).  
 
Lipid A is well conserved amongst Gram negatives, and combined with its essentiality it                           
has long been a target for the development of new antibiotics (Jackman et al, 2000). In                               
addition, engineering of strains with less immunogenic Lipid A have also been explored                         
for use as vaccine adjuvants (Needham et al, 2013).  
 
Variations in the number of acyl chains affects the ability of TLR4 to recognise Lipid A.                               
Six acyl chains has been demonstrated to elicit the strongest binding between Lipid A and                             
MD­2/TLR­4 (Park et al, 2009). LpxM/MsbB catalyses the final myristoylation step                     
during the synthesis of Lipid A, and its mutation did not affect growth but resulted in                               
penta­acylated Lipid A in  E. coli  (Clementz et al, 1997). Penta­acylated Lipid A in  E. coli                               
reduced immune activation and inflammatory responses and also reduced its virulence in                       
a mouse model, compared with the wildtype hexa­acylated Lipid A (Kim et al, 2004).                           
Similarly, the purified LPS from an  msbB mutant caused a 10,000 fold reduction in TNFɑ                             
production by monocytes (Somerville et al, 1996). 
 
Other host defence mechanisms which target Lipid A include the production of cationic                         
anti­microbial peptides (CAMPs). CAMPs are found in phagocytes, mucus layers and                     
secretions (Needham and Trent, 2013). These positively charged molecules are able to                       
bind and integrate into the negatively charged bacterial membrane, altering the membrane                       
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 potential and causing cell death (Kagan et al, 1990; Needham and Trent, 2013). In the                             
human intestinal epithelia, one of the most commonly expressed CAMPs are the                       
ɑ­defensins which are formed of β­sheets with 3 disulphide bridges (Peschel and Sahl,                         
2006). They have anti­microbial activity against diverse pathogenic species,                 
encompassing Gram negative and Gram positive bacteria, but also fungi and viruses                       
(Gallo and Hooper, 2012). CAMPs represent a broad spectrum defence against infection,                       
but bacteria have also found means of defending themselves against them. In  Salmonella                         
species, addition of positively charged groups to Lipid A via PhoP/PhoQ and PmrA/B                         
reduces the affinity of the positively charged CAMPs for the bacterial membrane (Guo et                           
al, 1998). 
 
Platelet Factor 4 (PF4) is a chemokine released upon activation of platelets, and is                           
another positively charged molecule that is able to bind to Lipid A. The PF4­Lipid A                             
complex triggers the production of specific antibodies. The bacterium then becomes                     




Attached onto the synthesised Lipid A is the core oligosaccharide. The inner core is                           
mostly well conserved, and consists of the relatively unusual sugars Kdo and Hep                         
(L­glycero­D­manno heptopyranose), with other common sugar residues decorating the                 
backbone (Heinrichs et al, 1998; Frirdich and Whitfield, 2005). The Kdo residue is                         
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 necessary for survival, and one unit of Kdo is the smallest possible core structure that                             
retains viability (Helander et al, 1988).  
 
KdsA is responsible for synthesising Kdo­8­phosphate from D­arabinose 5­phosphate                 
and phosphoenol pyruvate (Schnaitman and Klena, 1993). The resulting CMP­Kdo is                     
activated by KdsB, and attached to Lipid A by WaaA (Schnaitman and Klena, 1993).                           
Heptose residues are required for membrane integrity, and are synthesised by WaaC, and                         
transferred to the inner core by WaaF and WaaQ (Heinrichs et al, 1998). Phosphoryl                           
groups are added to the inner core by WaaP (Heinrichs et al, 1998).  
 
The outer core in  E. coli differs in composition but the structure consists of three linked                               
hexose sugars, usually of glucose, galactose, N­acetyl galactosamine and N­acetyl                   
glucosamine, that are attached by glycosyltransferases encoded by the  waa gene cluster,                       
with two side chain residues (Heinrichs et al, 1998; Erridge et al, 2002). For all  E. coli                                 
and  Salmonella species, the first residue is glucose (Heinrichs et al, 1998). The outer core                             
consists of more typical sugars compared with the inner core but is less well conserved                             
within a species, with 5 types found in  E. coli ; the K12 type and types R1­R4. Core R1                                   
and R4 are the most similar to each other, with one alteration between the side branch                               
(Amor et al, 2000). The R1 core type is the most common, while R3 predominates in                               
verotoxinogenic strains, but is not necessarily linked to virulence  per se  and may have                           




The O polysaccharide (or O antigen) is attached to the final sugar of the core by WaaL                                 
(Han et al, 2012). In ‘rough’ strains such as  E. coli K12, the outer core is the outer­most                                   
region of the membrane, and no O polysaccharide is attached (Amor et al, 2000). Strains                             
with LPS containing O polysaccharide are termed ‘smooth’. The O polysaccharide is a                         
polysaccharide made up of up to 40 repeats of 2­6 sugars (Lerouge and Vanderleyden,                           
2002). Unlike the core region of LPS, there is considerably more variation in the O                             
polysaccharide structure, with 186 different serotypes present in  E. coli and  Shigella                       
(Samuel and Reeves, 2003). The O polysaccharide is variable in the sugar composition,                         
linkages between units, and the number of repeats (Samuel and Reeves, 2003).  
 
The genes for synthesis of the O polysaccharide are found in clusters, with three groups                             
of genes generally required, for synthesis, formation of the O unit, and translocation and                           
polymerisation into the full O polysaccharide (Figure 1.2, Samuel and Reeves, 2003).                       
The first step occurs in the cytoplasm, where the sugar biosynthesis enzymes catalyse the                           
production of the sugar precursors. Glycosyltransferases then transfer the precursors to                     
the carrier lipid undecaprenyl pyrophosphate (UndPP) in the inner membrane, and then                       
transfer the subsequent precursors to form the oligosaccharide. Next, processing and                     
translocation occurs: wzx allows the UndPP linked O unit to transfer into the periplasm,                           
where wzy polymerises the units into the completed O polysaccharide, the length of                         
which is controlled by wzz (Samuel and Reeves, 2003). WaaL then catalyses the                         
56 








 The O polysaccharide is not essential for viability, but it is certainly associated with                           
survival, particularly outside of a laboratory setting (Reeves, 1995). Presence of O                       
polysaccharide can confer resistance to bacteriophages which use outer membrane                   
proteins as receptors prior to invasion (van der Ley et al, 1986; Ho and Waldor, 2007).                               
The O polysaccharide can also aid in responding to environmental conditions; In  M.                         
xanthus , the O polysaccharide is required for social motility and the formation of the                           
multi­cellular fruiting body, which occurs when nutrients are limited (Bowden and                     
Kaplan, 1998). At a pH of below 5,  H. pylori was found to increase transcription of  wbcJ ,                                 
a gene involved in O polysaccharide biosynthesis (McGowan et al, 1998).  wbcJ mutants                         
were found to be acid sensitive, and since  H. pylori is able to colonise the stomach which                                 
has a pH of around 2, it is possible that the O polysaccharide contributes to acid                               
resistance. The protozoan  Naegleria gluberi prey on  Salmonella species and are able to                         
select their choice of prey based on the expression of certain O polysaccharides,                         
suggesting that the wide variation in O polysaccharide composition has developed as a                         
means of avoiding predation (Wildschutte et al, 2004). The wide variation in the structure                           
of O polysaccharides cannot be explained as a mechanism to avoid immune detection; O                           
polysaccharides are highly immunogenic and many pathogenic strains express only one                     
type of O polysaccharide, when it would be more beneficial to alter this structure if it                               
would facilitate immune evasion.  
 
In the host, the presence of the O polysaccharide can reduce phagocytosis, and the longer                             
the O polysaccharide (up to 100 repeating units) the lower the level of ingestion of  S.                               
59 
 enterica by macrophages (Murray et al, 2006). A  P. aeruginosa strain that expressed an                           
unusually long O polysaccharide was not cleared from the blood during infection,                       
compared with the strain expressing shorter O polysaccharide (Ohno et al, 1995).                       
Likewise, a rough strain of  S. enterica was eliminated quickly from the bloodstream,                         
whereas the smooth strain persisted (Ohno et al, 1995).  
 
O polysaccharide can also increase resistance to complement and bile (Murray et al,                         
2006; Crawford et al, 2012). It is not just the length that can increase resistance to                               
complement and phagocytosis, as it was also observed in Salmonella that the differences                         
in the sugar composition affected the rate of uptake, and the virulent strains altered to                             
express O polysaccharides from less virulent strains were phagocytosed faster                   
(Liang­Takasaki et al, 1982). In addition, those expressing O polysaccharides from the                       
most virulent strains were the most resistant to phagocytosis, implying that the                       
carbohydrate composition of the O polysaccharide is able to alter the recognition by                         
macrophages. The density of O polysaccharide affects serum resistance, as Grossman et                       
al (1987) found that steric hindrance of the C5b­9 complex of complement requires a                           
minimum concentration of 4­5 O polysaccharide units per LPS molecule.  
 
Loss of O polysaccharide in the lung pathogen  Actinobacillus pleuropneumoniae caused                     
a defect in the ability to form biofilms (Hathroubi et al, 2016). In contrast, clinical                             
isolates of  P. aeruginosa showed no expression of O polysaccharide during biofilm                       
growth, but this was restored when in planktonic culture (Ciornei et al, 2009). The                           
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 ‘rough’ LPS isolated from the cells in the biofilm was also more immunogenic, and                           
induced an enhanced cytokine response compared with the planktonic smooth LPS                     
(Ciornei et al, 2009).  
 
Presence of O polysaccharide does not always confer enhanced pathogenicity; the                     
opposite effect is also observed.  Yersinia pestis is the causative agent of plague, and a                             
primary virulence factor is a surface expressed protease, Pla, which is able to activate                           
plasminogen in the bloodstream and cause proteolysis, leading to invasive and systemic                       
infections (Kukkonen et al, 2003). Activity of Pla is dependent on the absence of O                             
polysaccharide, likely due to the fact that its long chains would obscure Pla from its                             
target (Kukkonen et al, 2003). Studies in  S. flexneri  showed that rough mutants of                           
virulent strains were still able to invade HeLa cells, and transfer of the O polysaccharide                             
from a virulent smooth strain to an avirulent rough strain had no effect on its ability to                                 
penetrate epithelial cells (Okamura et al, 1983).  
 
The gastrointestinal pathogen  Yersinia enterocolitica contains a virulence plasmid, pYV,                   
but presence of this plasmid alone is not sufficient for pathogenesis, unless in                         
combination with the presence of O polysaccharide (Bengoechea et al, 2004). Strains                       
without O polysaccharide had an LD50 1000 fold higher than the parent strain, whereas                           
strains expressing just one O polysaccharide unit had an LD50 just 10 fold higher in a                               
mouse model of infection, suggesting expression of a single O unit can contribute to                           
virulence (Bengoechea et al, 2004). O polysaccharide has been linked with serum                       
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 resistance in other species. For  Y. enterocolitica , presence of O polysaccharide does not                         
confer serum resistance when grown at room temperature, but ‘smooth’ strains were                       
more resistant than the ‘rough’ strains when grown at 37 °C. The expression of its O                               
polysaccharide is temperature regulated, with highest expression at 25 °C, and lower                       
expression at 37 °C, the temperature within a host. Since other virulence factors of  Y.                             
enterocolitica are also temperature regulated, the O polysaccharide status may act as a                         
regulator or signal for expression of other virulence factors (Bengoechea et al, 2004;                         
Perez­Gutierrez et al, 2007).  
 
In this work, the role of O polysaccharide in OMV entry into host cells was studied in the                                   




EHEC O157 is an important human pathogen, spread via contaminated food and water,                         
and infects around 100,000 people per year in the USA (Rangel et al, 2005). Whilst the                               
number of infections is low compared with other enteric bacteria, such as  Campylobacter                         
jejuni or  Vibrio cholerae , the severity of disease and its complications, particularly in                         
children and the elderly, leads to the hospitalisation of up to 50% of those infected                             
(Eppinger and Cebula, 2015). All EHEC strains produce shiga­like toxins, but the O157                         
serotype is particularly virulent in humans and is responsible for the majority of cases of                             
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 acute hemorrhagic colitis, which can progress to hemolytic uremic syndrome (HUS) in                       
around 10% of cases in children under 10 years old (Tarr, 1995). Due to the low                               
infectious dose (less than 100 organisms) and the severity of symptoms, EHEC O157 is a                             
reportable disease agent and is responsible for significant outbreaks of disease, typically                       
originating from contaminated food, including meat, or vegetables such as cucumbers or                       
bean sprouts (Tarr, 1995). It also has a considerably higher mortality rate than other                           
serotypes of EHEC; an outbreak in Central Scotland in 1996, traced back to a butcher’s                             
shop, caused 279 confirmed cases and 21 deaths (Pennington, 2014).  
 
EHEC strains have a considerable armory of virulence factors. Shiga­like toxins are                       
potent virulence factors, but expression of toxins in non­pathogenic strains does not                       
enable them to cause disease (Law, 2000). EHEC O157 produces Stx2 type shiga toxin,                           
which is 1000 fold more toxic to endothelial cells than the Stx1 form (Louise and Obrig,                               
1995). The toxin is formed of 2 subunits: The 32 kDa A subunit, and a pentamer of 7 kDa                                     
units forms the B subunit ring. This binds to the host cell membrane via                           
Globotriaosylceramide (Gb3) and enters the cell through receptor mediated endocytosis.                   
Once inside the cell, if the A subunit has avoided lysosomal degradation, it is converted                             
to its active form by cellular proteases, whereupon it cleaves 28S ribosomal RNA and                           
inhibits protein synthesis, leading to cell death (Law, 2000). EHEC O157 is commonly                         
isolated from cattle, yet is not usually associated with disease in the animal host, and this                               
is proposed to be due to the lack of expression of the Gb3 receptor (Tree et al, 2009).  
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 The EHEC O157 chromosome also encodes a pathogenicity island known as the locus of                           
enterocyte effacement (LEE). The LEE genes encode proteins for the assembly of the                         
Type 3 secretion system, which enables both intimate attachment to host cells, via                         
intimin, and the direct secretion of proteins into the host cell, facilitating rearrangements                         
in the actin cytoskeleton. This results in actin ‘pedestals’ on cultured cells, which                         
promote colonisation of EHEC, and causes attaching and effacing (A/E) lesions in the gut                           
(Tree et al, 2009).  
 
EHEC O157 is far more commonly associated with human disease than other EHEC                         
serotypes, despite expression of the same virulence factors. The O157 O polysaccharide                       
has been suggested as a possible virulence factor (Ho and Waldor, 2007). Synthesis of the                             
O157 antigen in EHEC requires a 14 kb gene cluster. These genes encode 5 enzymes for                               
synthesis of the sugar units, 4 transferases to export to the inner membrane, 1 flippase to                               
transfer across the outer membrane and 1 polymerase to add the subunits together to form                             
the long O polysaccharide (Wang and Reeves, 1998). Sequence analysis of the genes for                           
O polysaccharide biosynthesis revealed that the transferases, flippase and the polymerase                     
are unique for the synthesis of O157 (Wang and Reeves, 1998). The O157 subunit is                             
comprised of N­acetyl D­perosamine, L­fucose, D­glucose and N­acetyl D­galactose                 
(Shimizu et al, 1999). Precursors of the O polysaccharide unit are assembled onto                         
Und­P­P at the inner membrane by transferase enzymes, prior to their diffusion across the                           
outer membrane and their polymerisation into the completed O polysaccharide (Samuel                     
and Reeves, 2003). In EHEC, the  gne gene encodes an epimerase enzyme required for the                             
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 synthesis of GalNAc­PP­Und lipid intermediate, the precursor for the first GalNAc unit                       
(Figure 1.2, Rush et al, 2010). 
 
Analysis of the O157 O polysaccharide determined an average length of 30 nm, and the                             
length of the O polysaccharide was positively correlated with its adhesive strength                       
(Strauss et al, 2009). Other studies have also linked O157 to adherence. EHEC mutants                           
lacking the O157 antigen had a reduced ability to bind to lettuce compared with the                             
wildtype, and this may be due to the increased hydrophobicity of the cells in the absence                               
of the hydrophilic O polysaccharide (Boyer et al, 2011). The ability of EHEC to survive                             
and contaminate food surfaces is key to its route into humans to facilitate disease. O                             
polysaccharide deficient mutants showed impaired growth and survival in a silkworm                     
model, due to their increased sensitivity to anti­microbial peptides and serum, and were                         
also unable to colonise and kill the host compared with the wildtype (Miyashita et al,                             
2012). Similarly, O157 negative mutants were 100 fold more sensitive to an AMP                         
produced by the epithelial cells of the intestine, which would significantly impair the                         
ability to colonise the gut (Ho and Waldor, 2007). 
 
Cattle are reservoirs of EHEC O157. Clearance of infection occurred faster for O                         
polysaccharide negative EHEC, compared with the wildtype EHEC O157. After 32 days,                       
6 of the 7 cattle infected with the O polysaccharide deficient strain were culture negative,                             
compared with only 1 of the 7 for EHEC O157, indicating that the O polysaccharide                             
plays a role in colonising and persisting within the bovine intestine (Sheng et al, 2008).  
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 The  wzz gene in  E. coli controls O polysaccharide chain length. Typically, O                         
polysaccharides of  E. coli contain 10­18 repeats (Osawa et al, 2013). Mutations or                         
deletions in  wzz lead to variations in the chain length, and in these experiments, three                             
different phenotypes were generated: short chain (with less than 15 units), intermediate                       
(with 15­20 units) and long (over 20 units). The strains with longer chain lengths had a                               




Enteroaggregative  E. coli (EAEC) are pathogenic strains which cause diarrhoea and are                       
able to form characteristic aggregative biofilms in the intestinal tract, as well as a                           
characteristic ‘stacked brick’ pattern of adhesion to epithelial cells  in vitro (Wilson et al,                           
2001; Chaudhuri et al, 2010). Unlike for EHEC, animals are not considered to be a                             
reservoir for disease, and instead EAEC is typically acquired from its ability to grow on                             
food sources (Okhuysen and Dupont, 2010). EAEC infection is commonly associated                     
with ‘travellers diarrhoea’ and is prevalent in Africa and South America, where it can be                             
endemic in the population, especially in children (Harrington et al, 2006; Okhuysen and                         
Dupont, 2010). EAEC is frequently detected in patients with diarrheal disease, and in one                           
large cohort study in the UK, it accounted for almost 5% of 3506 cases, compared with                               
just 0.1% for EHEC O157, and 4% for  Salmonella (Wilson et al, 2001). It was also found                                 
in healthy people, and was detected in 1.7% of 2772 control samples, whereas only 0.4%                             
of samples contained Salmonella , and EHEC O157 was not detected at all (Wilson et al,                             
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 2001). This indicates that, unlike O157, presence of EAEC is not always associated with                           
disease, and as EAEC infection commonly affects the immunocompromised and HIV                     
patients, it may be that the immune system can typically control infection to an extent                             
(Garcia et al, 2010). The sub­clinical persistence of EAEC in the generally hostile                         
environment of the gut, even in healthy subjects, may be due to the formation of its thick,                                 
aggregative biofilms that help it to evade immune responses, and confer protection from                         
anti­microbial peptides and antibodies (Okhuysen et al, 2010). EAEC triggers                   
pro­inflammatory responses through the interaction of flagellin with Toll­like receptor 5,                     
causing the release of IL­8 (Khan et al, 2004).  
 
Persistent diarrhoea is an illness that affects millions of children globally, particularly in                         
the developing world, where malnutrition is both a risk factor and an outcome of the                             
disease (Lima et al, 2000). A study in Brazil found that EAEC was responsible for 68%                               
of cases of persistent diarrhoea in children under 3 years of age (Fang et al, 1995). In a                                   
neonatal mouse model, persistent EAEC infection caused up to 47% growth impairment,                       
and malnutrition increased the burden of infection by up to 4 logs (Roche et al, 2010).                               
Persistent EAEC infection can therefore lead to a continual cycle of malnutrition and                         
diarrhoea, especially in impoverished communities with poor sanitation (Lima et al,                     
2000). 
 
The aggregation and adherence of EAEC is conferred by the plasmid pAA. The genes of                             
pAA are used clinically to distinguish EAEC from commensal  E. coli  (Harrington et al,                           
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 2006). Transfer of this plasmid to K12 also transferred its aggregative ability (Nataro et                           
al, 1992). pAA encodes the genes for the highly positively charged                     
aggregative­adherence fimbriae (AAF). The transcription of genes on pAA is controlled                     
by AggR, upstream of which is a gene encoding a small, immunogenic 10.2 kDa protein                             
known as dispersin (Sheikh et al, 2002). Dispersin mutants show hyperaggregation,                     
indicating the role of this protein is to counteract the AAF and reduce aggregation, which                             
may then allow the bacteria to penetrate the intestinal mucus layer (Sheikh et al, 2002).                             
Dispersin is secreted to the outer membrane of the bacterial cell, where it non­covalently                           
binds to LPS. Dispersin is hydrophilic, unlike AAF, and so its abundance on the                           
membrane may act to reduce the auto­aggregation of the hydrophobic fimbriae by                       
preventing their interactions (Sheikh et al, 2002).  
 
EAEC also secretes a 116 kDa serine protease autotransporter known as Pic. This protein                           
was demonstrated to have a nutritional role for EAEC; it allowed use of mucin as a                               
carbon source, allowing the removal of the thick mucus layer that can inhibit colonisation                           
of the intestinal epithelium, but also providing a nutritional benefit to the cells in an                             
environment where sources of nutrients can be limited (Harrington et al, 2009).  
 
O42 is a common serotype of EAEC (Chaudhuri et al, 2010). Although it was observed                             
that EAEC can be carried asymptomatically, 3 out of 5 adults infected with EAEC O42                             
developed diarrhea, while the other three EAEC serotypes investigated did not cause                       
disease in any of the subjects (Nataro et al, 1995). The O42 antigen subunit is comprised                               
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 of 4 sugars: Glycero a­D glucopyranose, 2­acetamido 2­deoxy b­D Glucopyranose,                   
2­acetyl b­D galactofuranose and a­D N­acetyl glucopyranose.  wbaC  encodes a mannosyl                     
transferase, which catalyses the formation of mannosyl linkages between the residues,                     




E. coli K12 has been used in laboratory settings as a model organism for almost a century                                 
(Browning et al, 2013). It was originally isolated from a fecal sample from a diphtheria                             
patient (Bachmann, 1972). Since this isolation in 1922, it has undergone a series of                           
mutations that have enabled it to adapt to its life in the laboratory (Stevenson et al, 1994).                                 
Culturing of  E. coli in the lab is not representative of their natural habitats (Fux et al,                                 
2005). Laboratory strains of  E. coli appear to readily lose their O polysaccharide,                         
suggesting that it is not advantageous in this context, in contrast to  E. coli isolated in the                                 
‘wild’ which almost invariably express O polysaccharide (Stevenson et al, 1994). A K12                         
strain, MG1655, is a ‘rough’ strain that has undergone an IS­5 insertion, called the rfb50                             
mutation, in the  wbbL gene of the rfb cluster, causing loss of expression of its native O16                                 
O polysaccharide (Liu and Reeves, 1994).  wbbL was found to encode a rhamnosyl                         
transferase, required for the addition of rhamnose as the second sugar in the O16 subunit                             
(Figure 4.1, Stevenson et al, 1994). The O16 antigen subunit consists of N­acetyl                         
glucosamine, a­L rhamnose, a­D glucose, and B­D galactofuranose (Stevenson et al,                     
1994).  
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 When expression of the O16 antigen was restored to generate MG1655 L9, it was able to                               
colonise the intestine of  Caenorhabditis elegans  and cause disease, suggesting that the O                         
polysaccharide is a requirement for pathogenesis (Browning et al, 2013). It also casts                         
doubts upon the use of K12 as a model organism, when it does not replicate the behaviour                                 
of its restored O polysaccharide counterpart, let alone naturally occurring strains of  E.                         
coli  (Browning et al, 2013).  
 
Sequence comparisons of K12 and O157 revealed that K12 has not lost the genes                           
necessary for pathogenesis, but in fact O157 has acquired them (Hooper and Berg, 2002).                           
Around 4.1 kb of chromosomal DNA is conserved in  E. coli  strains, but the EHEC O157                               
chromosome is 5.5 kb. However, it does not just gain genes, as it has also lost 0.53 kb                                   
that is present in K12, suggesting it has selected its genome during its evolution as a                               
successful pathogen (Perna et al, 2001; Lim et al, 2010).  
 
The use of OMVs as delivery vehicles for virulence factors by pathogenic strains has                           
been well established. The vast majority of Gram negative bacteria in the human body are                             
non­pathogenic. However, this does not mean that they are harmless. OMVs released by                         
the avirulent DH5ɑ were able to enter cells of the intestinal line Caco­2 and induce DNA                               
damage and production of free radicals, similar to the effects caused by OMVs from a                             
pathogenic invasive strain of  E. coli (Tyrer et al, 2014). Since all species of Gram                             




Whilst understanding and appreciating the behaviour and contributions of OMVs to                     
bacterial fitness is an area of increasing interest, there are still many methodological                         
barriers to overcome. The primary aim of this work is to address the need for a new                                 
approach to studying the entry kinetics of OMVs into host cells, through the development                           
of an assay that can sensitively and quantitatively monitor their uptake in real time.  
 

















The strains used in this study were the  E. coli serotype O157:H7 strain Sakai 813, a                               
derivative of enterohaemorrhagic  E. coli (EHEC) RIMD 0509952, and its O                     
polysaccharide deficient derivative, MA6 (∆ gne,  Rump et al, 2010); the  E. coli serotype                         
O42 wild type strain (an enteroaggregative  E. coli isolate, Chaudhuri et al, 2010), and its                             
isogenic, O polysaccharide deficient derivative strain  (∆wbaC , Browning et al 2013); the                       




pBad24 ClyA­Bla and Bla­ClyA (provided by Matthew DeLisa, Cornell University) and                     
pBad18 KanR were all digested using NcoI and HindIII restriction enzymes (NEB) at 37                           
℃ for 2h. The digested products were run on a 0.8 % agarose gel at 100V for 1h. The                                     
new vector and insert bands were excised from the gel and purified using the Qiagen Gel                               
Extraction kit. 1 μl of vector was added to 13 μl of insert, with QuickStick DNA ligase                                 
for 15 minutes at room temperature to ligate the insert and vector. The ligation mixture                             
was then transformed into chemically competent  E. coli 5­alpha (NEB) using the heat                         
shock protocol and plated on Lysogeny Broth (LB) agar with 50 μg/ml kanamycin                         
(Sigma) overnight at 37℃ (Froger and Hall, 2007). Colonies were then selected, and the                             
plasmid was isolated using a Qiaprep plasmid miniprep kit (Qiagen). 5 μl of purified                           
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 plasmid was added to 100 μl of electrocompetent EHEC, EAEC and MG1655 strains in                           
0.1 cm electrocuvettes (BioRad) on ice, and transformed using electroporation with the                       
BioRad Micropulser, before outgrowth in SOC media (NEB) for 1h at 37℃. Cells were                             
plated onto LB Kan overnight at 37℃ (Gonzales et al, 2013). To verify the presence of                                 
the ligated plasmid and insert, colonies were added to 5 ml LB and grown overnight at 37                                 
℃, with shaking at 200 rpm, and the following day, plasmid was isolated from 1 ml of                                 
cells, using a Qiaprep plasmid miniprep kit (Qiagen) and 10 μl was digested again with                             
NcoI and HindIII (NEB) for 1h at 37℃. After digestion, 10 μl DNA loading dye (NEB)                                 
was added to the digestion mix, and run on a 0.8 % agarose gel stained with SybrSafe                                 





Overnight cultures of EHEC, EAEC and MG1655 containing pBad ClyA Bla or Bla                         
ClyA were set up in 5 ml LB with 50 μg/ml Kanamycin (Sigma). The following day, the                                 
cultures were diluted 1:100 in 100 ml LB and were grown at 37℃, with agitation at 200                                   
rpm until OD600nm reached 0.5­0.6. The cells were then induced with 0.2% L­arabinose                         
(Sigma) and grown for a further 16h. Cells were pelleted for 20 minutes at 6000 xg, and                                 
the supernatants were removed and filtered with a 0.45 μm syringe filter (Merck).                         
Aliquots of filtered supernatants were spread on LB agar and grown overnight at 37℃ to                               
check that all viable cells had been removed by filtration. 25 ml of filtered supernatants                             
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 were centrifuged in a Beckman XL90 ultracentrifuge using a 70Ti rotor at 100,000 xg                           
(32,000 rpm) for 2h, 4 ℃. After centrifugation, supernatants were removed, and the                         




For fluorescently labelled vesicles, 1 μl of 1x Cellmask Orange plasma membrane stain                         
(ThermoFisher) was added to 1 ml isolated OMV fractions for 1h, in the dark with gentle                               
shaking, at room temperature. After 1h, the OMV samples were ultracentrifuged as                       




Nanoparticle tracking analysis allows for the measurement of size distribution and                     
concentration of nanosized particles suspended in liquid by tracking their Brownian                     
motion and the scattering of laser light (Filipe, Hawe and Jiskoot, 2010). After                         
purification, 1 ml of OMV samples were diluted by adding 10 μl of the neat fraction to                                 
1000 μl of filtered sterile PBS for a 1:100 dilution, and this was repeated twice more for                                 
1:10,000 and 1:1,000,000 dilutions. Particle diameter and concentration was measured                   
using the Nanosight LM10 (Malvern) nanoparticle tracking analysis, with a minimum of                       





The Malvern Zeta sizer applies an electric charge to particles in a solution, and the rate of                                 
their movement is related to their zeta potential and surface charge (Clogston and Patri,                           
2010). 700 μl of OMVs were added to cuvettes and the surface charge of the sample was                                 
measured using the Malvern Zeta sizer. An average of 30 readings was used to determine                             




10 μl of isolated outer membrane vesicles in sterile deionised distilled water were added                           
to 400­mesh copper grids, and negatively stained with 4% uranyl acetate for two minutes.                           




To quantify levels of protein in cell fractions, the ThermoFisher CBQCA Protein                       
Quantitation kit was used. 10 μl of protein was added to 125 μl 0.1M sodium borate, 5μl                                 
20mM KCN, and 10 μl 5 mM ATTO­TAG in a 96 well plate, and incubated in the dark                                   
for 1­2h. The fluorescence in samples was measured with an excitation at 465 nm and an                               
emission at 550 nm in a FluoStar OMEGA plate reader. The level of fluorescence in                             
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50 μl of samples were added in triplicate to a 96 well plate. Nitrocefin (Oxoid) was                               
diluted to 0.5 mg/ml in PBS and 50 μl was added to each sample. The absorbance at 486                                   
nm was measured in the FluoStar Omega plate reader for 2h, and the change in                             




12 μl samples from EHEC ClyA­Bla and whole cell lysate, supernatant and OMV                         
fractions (induced, uninduced) were added to 3 μl 5X SDS loading dye and boiled for 10                               
minutes. Samples were loaded onto a 15 well BioRad pre cast stain­free SDS PAGE gel                             
and run at 120 V, 200 mA for 45 minutes. The gel was then transferred onto a PVDF                                   
membrane in transfer buffer containing 20% methanol for 80 minutes at 100 V. After                           
transfer, the membrane was blocked at room temperature in TBS 0.1% Tween­20 and 5%                           
non fat milk for 1h with agitation (Liu et al, 2014). The membrane was washed 3X with                                 
TBS 0.1% Tween­20 (5 minutes per wash). After blocking, the membrane was incubated                         
with a 1:2000 dilution of mouse anti­bla primary antibody (Abcam) in TBS 0.1%                         
Tween­20 and 5% non fat milk overnight at 4℃ with agitation. The following day, the                               
membrane was washed 3X as before, and incubated with a 1:5000 dilution of sheep                           
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 anti­mouse secondary antibody (Sigma) in TBS 0.1% Tween­20, 5% non fat milk for 1h                           
at room temperature with agitation (Liu et al, 2014). The membrane was washed again                           




The detergents Triton X­100 and SDS were added at a concentration of 1% to 20 μl                               
OMVs for 45 minutes at 37 ºC to disrupt OMV membranes. 5 μl of 0.01% cysteine                               
protease papain (Sigma) was then added for 30, 45 or 60 minutes at 37 ºC to degrade                                 
proteins in the sample. The papain reaction was inactivated using 1 mM of the serine                             
protease inhibitor PMSF at room temperature for 30 minutes. 5 μl SDS­PAGE loading                         
dye was added to the samples, which were then boiled for 10 minutes. Samples were run                               
on a 15 well pre­cast stain free gel (BioRad) for 45 minutes at 120V, and then proceeded                                 








HeLa (Human cervical epithelial) cells (ATCC number CRM­CCL­2)  were maintained in                     
Dulbecco’s Modified Eagle Medium, (DMEM, Sigma) with 1000 mg glucose per litre,                       
and supplemented with 1% L­glutamine, 1% Penicillin/Streptomycin and 10% heat                   
inactivated fetal bovine serum (FBS, Sigma). Cells were grown at 37 ºC, 5% carbon                           
dioxide, and were split via trypsinisation upon reaching 60­80% confluency in T75                       
culture flasks. 
 
RKO (human colonic epithelial) cells (ATCC number CRL­2577) (Ahmed et al, 2013)                       
were maintained in DMEM with 4500 mg glucose per litre (Sigma), with 1%                         
L­glutamine, 1% Penicillin/Streptomycin and 10% heat inactivated fetal bovine serum                   
(FBS, Sigma). Cells were grown at 37 ºC, 5% carbon dioxide, and were split via                             
trypsinisation upon reaching 60­80% confluency in T75 culture flasks. 
 







HeLa cells (P3­7) were seeded on 13 mm coverslips in a 12 well plate at a concentration                                 
of 1x10 5 cells per ml in complete DMEM 24h prior to infection. For infection with                             
reporter OMVs, cells were washed and loaded with 100 μl 6X CCF2­AM dye with 500 μl                               
colourless unsupplemented DMEM, and incubated in the dye solution for 1h at room                         
temperature in the dark. Cells were then infected with 15 μg/ml reporter OMVs for 0­4h                             
at 37 ºC. The cells were washed with PBS and then fixed with 0.5 ml 4% PFA for 15                                     
minutes. The next day, coverslips were mounted onto slides with a drop of Gold                           
Anti­Fade mounting solution (ThermoFisher) and then imaged using the Nikon A1R                     
confocal microscope (Birmingham Advanced Light Microscopy Facility), with               
fluorescence observed from excitation at 409 nm and two separate emissions at 460 nm                           
and 530 nm, to visualise green and blue cells. Z stacks were produced from 20 slices,                               
from the top to bottom of cells to show the distribution of fluorescence throughout the                             




HeLa cells (P3­7) were seeded on 13 mm coverslips in a 12 well plate at a concentration                                 
of 1x10 5 cells per ml in complete DMEM 24h prior to infection. The following day, cell                               
mask orange labelled OMVs were added to cells at a concentration of 10 8 vesicles per ml.                               
Cells were incubated with OMVs at 37 ºC for 10 minutes, or 60 minutes, prior to fixation                                 
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 with 0.5 ml 4% PFA for 15 minutes at room temperature. Coverslips were mounted as                             
before, and slides were imaged using an Olympus IX83 inverted microscope fitted with a                           
FV3000 confocal system and 100x Super Apochromat oil objective. Images were                     























HeLa cells or RKO cells (passage 1­7) were seeded in triplicate in a black­walled, clear                             
bottom 96­well plate (Greiner) at a concentration of 1x10 5 cells per ml in complete                           
Dulbecco’s modified Eagle medium (DMEM) supplemented with 1% L­glutamine, 1%                   
Penicillin/Streptomycin and 10% heat inactivated fetal bovine serum. The plate was                     
incubated at 37 ºC, 5% CO 2 for 24h prior to experiments. The following day, cells were                               
loaded with 20 μl 6X CCF2­AM with 100 μl colourless DMEM (cDMEM) with 10mM                           




HeLa cells were seeded in 24 well plates at a concentration of 1x10 5 cells per ml in                                 
complete DMEM as before. Overnight cultures of EHEC ClyA Bla and EHEC empty                         
vector were set up in 5 ml LB, and grown at 37 ºC with shaking at 200 rpm. The next day,                                         
the bacterial cultures were diluted 1:100 in colourless unsupplemented DMEM, HeLa                     
cells were washed and media was replaced with 700 μl colourless DMEM with 10 mM                             
HEPES, and 200 μl of bacterial culture was added to 0.4 μm transwells above the cells.                               
0.2% L­arabinose was added to the bacterial cells to induce plasmid expression. The plate                           
was added to the Phera Star Omega (BMG) plate reader at 37 ºC. The wells were scanned                                 
(bottom optic) with orbital averaging, with excitation at 405 nm and simultaneous dual                         
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For inhibition experiments, cells were treated with previously verified chemical inhibitors                     
of endocytic pathways. HeLa cells were treated with 5 mM methyl­β cyclodextrin (mbcd)                         
to remove cholesterol (Contreras et al, 2010) or 1 μg/ml filipin to bind cholesterol                           
(Ilnytska et al, 2013), 80 μM Dynasore for dynamin inhibition (Girard et al, 2011), or 20                               
μM blebbistatin for macropinocytosis inhibition (Ramanathan et al, 2015) (all Sigma), for                       
1h prior to infection at 37 ºc. Cells were treated with 1 μg/ml chlorpromazine for 1h at 37                                   
ºc to inhibit formation of clathrin coated pits (Papatheodorou et al, 2010). Wells were                           
washed with 100 μl PBS prior to infection. To remove surface proteins, 5 μg/ml of the                               
cystein protease papain (Sigma) was added for 15 minutes at 37 ºc, before inactivation of                             




Rough LPS (from  E. coli  EH100 Ra mutant strain, Sigma) or smooth LPS (from  E. coli                               
O55:B5, Sigma) was added at a concentration of 1 μg/ml for 30 minutes prior to                             
infection, at 37 ºC. The TLR4 inhibitor C34 (Sigma) was added at a concentration of 10                               





The CBQCA protein quantitation kit was used to determine the protein concentration in                         
isolated OMVs, which were then diluted in cDMEM and added to the cells for a final                               
protein concentration of 10 μg/ml to allow for OMVs from the same isolation to be used                               
for all the biological and technical replicates (Jager et al, 2015) This concentration was                           
determined using the Nanoparticle tracking analysis to be equivalent to 1x10 8 vesicles.                       
HeLa cells were seeded at a concentration of 1x10 5 cells per ml, corresponding to an                             
MOI of 1000. This MOI (equivalent to 10 μg/ml) represents a relatively low number of                             
OMVs, in comparison with other studies which have used up to 250 μg/ml, to test the                               
sensitivity of the assay (Chitcholtan et al, 2008). After addition of OMVs, the plate was                             
immediately placed in the PheraStar Omega (BMG) plate reader, with excitation at 405                         
nm and simultaneous dual emission at 530 nm and 460 nm. The wells were scanned                             




The ratio of blue to green fluorescence intensity detected in the cells at each cycle was                               
calculated using GraphPad Prism, as an indicator of OMV uptake. Ratios for uninfected,                         
dye­loaded cells were used as the baseline value for each cycle. All traces were                           
normalized to 0 for their first ratio value. All experiments were performed with three                           
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 technical replicates and three biological replicates. Means and standard deviation were                     
plotted over time. 
 
Efficiency of uptake was calculated as the total change in blue:green fluorescence                       
intensity ratio after 3h. Three technical replicates and three biological replicates were                       
performed for each plate reader experiment and these were treated as 9 independent                         
replicates. An ANOVA with correction for multiple comparisons, with a Brown Forsythe                       
test for equal variance, was used to determine the statistical significance of the total                           
change between samples and between samples and the relevant controls, or a Student’s t                           




To estimate the gradients of the data, polynomials were fitted to each data set generated                             
from the fluorescence assay using the cubic spline function  csaps in Matlab (by Dr. Sara                             
Jabbari, School of Mathematics, University of Birmingham). Numerical estimates of the                     
gradients of the resulting polynomials were determined using the  gradient function. To                       
ensure that the gradient estimates were as smooth as possible whilst also retaining the                           
overall shape and trend of the data, a small smoothing parameter was used.  
 
As before, an ANOVA with correction for multiple comparisons was used to analyse data                           
sets, with a Brown Forsythe test to determine equal variance using GraphPad Prism                         
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 software,  with multiple comparisons used to assess differences between experimental                   









The discrepancies in previous observations of OMV entry and cargo delivery may be                         
attributable to the different methods used in these studies, demonstrating the need for an                           
assay that can detect OMV entry processes in a consistent and repeatable manner. This                           
chapter describes a novel assay to continuously measure OMV uptake and cargo delivery                         
to host cells with high sensitivity, that is adaptable for high throughput screening, and                           
explores the kinetics of OMV interactions with host cells.  
 
This assay relies on the use of a genetically encoded hybrid reporter probe that is carried                               
by OMVs. ClyA, a cytolysin that is preferentially targeted into OMVs by E. coli , acts as                               
the targeting component, and is fused to β­lactamase at either the C­ or N­terminus,                           
which acts as the reporter component (Kim et al, 2008). This fusion disrupts the ability of                               
ClyA to assemble into its toxic oligomeric conformation (Kim et al, 2008). Host cells are                             
incubated with CCF2­AM, a dye composed of a covalently linked coumarin and                       
fluorescein molecule. The dye readily enters the host cells, where it is modified by                           
esterases, preventing its exit from the cell. Uncleaved CCF2­AM has an emission at 530                           
nm, detected as green fluorescence. When the reporter OMVs enter the host cells, the                           
β­lactamase cargo is able to cleave the bond between the dye molecules, causing a                           
disruption to FRET, and a detectable shift in emission from green (530 nm) to blue (460                               
nm) (Figure 3.2A). This shift in emission can be monitored in real time to determine the                               
rate of uptake and delivery of OMV cargo to host cells, by comparing the ratio of blue to                                   
86 
 green fluorescence intensity as an indicator of OMV­host cell interactions. This method                       


































pBad vector alone or containing ClyA­Bla or Bla­ClyA fusion genes were isolated from                         
transformed EHEC strains, and digested with NcoI and HindIII. Digested samples were                       






Outer membrane vesicles were isolated from EHEC ClyA­Bla (C­terminal fusion) and                     
EHEC Bla­ClyA (N­terminal fusion). The OMVs containing β­lactamase enter host cells                     
and cleave the cephalosporin ring connecting the fluorescein and coumarin molecules,                     
causing a disruption to FRET, using a single excitation at 405 nm, and the separation of                               
these fluorescent molecules will cause a detectable change in emission from green (530                         
nm) to blue (460 nm) (Figure 3.2A). Anti­Bla Western blotting showed presence of the                           
intact 69 kDa ClyA­Bla fusion protein in samples from EHEC whole cell lysate,                         
supernatant and OMVs, suggesting that the fusion protein is targeted to and retained in                           
OMV fractions, as previously reported (Kim et al, 2008) (Figure 3.2B). The β­lactamase                         
activity was detected by its ability to hydrolyse nitrocefin, indicated by an increased                         
absorbance at 486 nm, and the specific β­lactamase activity was determined by the                         
change in absorbance normalised to the total protein concentration measured in each                       
sample using the CBQCA protein quantitation kit (Figure 3.2C). The specific activity was                         
high in the OMV samples, suggesting efficient localisation and expression of active                       
β­lactamase in the isolated OMV fractions. Triton treatment to lyse the vesicles resulted                         
in increased β­lactamase activity in the N­terminal fusion Bla­ClyA OMVs, while there                       






Using reporter probes, this assay can monitor uptake of OMVs into host cells in real time                               
(A). Western blotting of cell fractions showed that the ClyA­Bla probe is exposed and                           
incorporated into vesicles (WCL= whole cell lysate, sup= supernatant, OMV= outer                     
membrane vesicle, WT= wildtype) (B). The β­lactamase within the reporter OMVs is                       
active and able to hydrolyse nitrocefin (C) Data shown are the mean specific activities of                             
3 technical replicates. Error bars represent standard deviation.   
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 Transmission electron microscopy (TEM) was used to observe their morphology which                     
showed intact spherical membranous particles, confirming that the ClyA­Bla fusion                   
protein has no observable effect on OMV morphology (Figure 3.3A). The size and                         
concentration of OMVs was determined using Nanoparticle Tracking Analysis (NTA),                   
which allows for the measurement of size distribution and concentration of nanosized                       
particles suspended in liquid by tracking their Brownian motion and the scattering of                         
laser light (Filipe, Hawe and Jiskoot, 2010), with a minimum of 200 tracks per sample                             
(Figure 3.3B). Average OMV concentration was 5 x 10 12 particles per ml, with size                           
ranging from 10­400 nm in diameter, with a mean of 134 nm. The size ranges were in                                 
accordance with data obtained previously for OMVs from  E. coli (Kim et al, 2008).  
 
Expression of the probe did not affect the number of OMVs produced, determined by                           
comparing the OD of cultures, prior to isolation, with the number of OMVs detected by                             
Nanosight (Figure 3.3 B, C). There was an average of 38 OMVs isolated per cell by                               
wildtype EHEC, and 41 OMVs per cell for EHEC ClyA Bla strains (Figure 3.3 C).  
 
The Malvern Zeta sizer applies an electric charge to particles in a solution, and the rate of                                 
their movement is related to their zeta potential and surface charge (Clogston and Patri,                           
2010). Probe expression did not change OMV charge (Figure 3.3D). Values between +10                         
mV and ­10 mV are considered to be uncharged (Clogston and Patri, 2010). In EHEC                             
ClyA­Bla, protease protection experiments revealed that the probe is oriented with Bla                       
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Expression of the probe does not change vesicle morphology, as observed with                       
Transmission Electron microscopy (A) or size, using Nanosight particle tracking analysis                     
(B). Data shown represent 3 technical replicates, with a minimum of 100 tracks per                           
sample. Black line represents median size value. Production of OMVs was not affected by                           
probe expression (C). Data represents one biological replicate. The probe has no effect                         
on charge, as determined using Zeta potential analysis (D). Data represents mean charge                         
from 30 readings of one biological replicate. OMVs were treated with papain prior to                           









Lipid membranes of OMVs were fluorescently labelled with the lipophilic dye Cellmask                       
Orange prior to infection of host cells. HeLa cells were incubated with labelled OMVs                           
for 10 minutes or 60 minutes prior to fixation, and were then imaged using confocal                             
microscopy (Figure 3.4A). This revealed rapid entry and trafficking of vesicles into host                         
cells, and highlighted the requirement of a real­time approach to study OMV uptake.                         
HeLa cells were then infected with the reporter OMVs from EHEC, followed by fixation                           
at 0h or 4h, to represent early and late timepoints of infection, and imaged using confocal                               
microscopy to visualise blue and green fluorescence. There was an observable colour                       
change from green to blue in HeLa cells infected with reporter OMVs compared with                           
uninfected cells or those infected with the vector only control OMVs (Figure 3.4B). This                           







Fluorescently labelled OMVs were incubated with HeLa cells for 10 or 60 minutes, and                           
were visible inside the cells at both time points, observed using confocal microscopy (top                           
and side view of Z stack) (A). Scale bar = 10 μm. Reporter OMVs caused a colour                                 





Next, the kinetics of vesicle entry into host cells were investigated. The confocal                         
microscopy experiments revealed that reporter OMVs had caused almost complete colour                     
change in host cells by 4h, so the plate reader experiment was run for 0­3h to capture the                                   
kinetics of uptake. In the plate reader experiments, the fluorescence in dye loaded HeLa                           
cells at 530 nm (green, uncleaved) and 460 nm (blue, cleaved) was measured                         
simultaneously every 90 seconds to determine the speed and efficiency of β­lactamase                       
entry and dye cleavage within the cells. The rate and maximum rate was calculated from                             
estimating the change in gradient over time, whilst the efficiency of uptake was                         
calculated from the total change in blue:green fluorescence ratio over the 3h experiment. 
 
There was an increase in the blue:green fluorescence intensity ratio over time for HeLa                           
cells infected with reporter OMVs for 3h, compared with cells infected with empty vector                           
control OMVs from EHEC (Figure 3.5A). The gradient over time showed a faster rate of                             
change for cells infected with ClyA Bla OMVs compared with Bla ClyA or empty vector                             
(Figure 3.5B). There was an increase in the maximum rate of change from green to blue                               
in cells infected with reporter OMVs (Figure 3.5D) and a significant difference in the                           
total change after 3h (Figure 3.5C). These results showed that the β­lactamase from the                           
reporter OMVs is able to enter host cells and cause dye cleavage and a change in                               
emission from green to blue. The slower rate of change for EHEC Bla ClyA OMVs is                               
probably due to the N­terminal fusion of ClyA to β­lactamase, resulting in Bla facing the                             
interior of the OMV and not becoming exposed immediately upon cell entry (Kim et al,                             
96 
 2008). Entry of OMVs via fusion of lipid membranes may prevent internalisation of the                           
β­lactamase probe from the OMV surface to the cell cytoplasm, and so fusion could be                             










Figure 3.5. Probe OMVs can be detected upon entry into host cells, and capture                           
dynamics of entry in real time. OMV uptake (Y axis) is defined as the ratio of blue:green                                 
fluorescence measured over 3h, as an indication of entry of β­lactamase from the reporter                           
OMVs into host cells, where cleavage of CCF2­AM substrate then occurred (A). Data                         
shown are means with SD, with three technical replicates for each of three separate                           
experiments. Efficiency of uptake was defined as the total change in blue:green ratio over                           
3h, and was highest in cells infected with ClyA­Bla OMVs (C). The gradient of the colour                               
change was calculated (rate, Y axis) (B) and the maximum rate of change was                           
determined as the highest change in gradient over the 3h (D). ANOVA was used to                             
analyse results in C and D, with a Brown Forsythe test for equal variance. Replicates                             
were treated as 9 independent replicates, and corrected for multiple comparisons                     
98 





E. coli is primarily found in the intestine of mammalian hosts (Tenaillon et al, 2010). The                               
previous experiments were conducted in HeLa cells, where the CCF2 reporter system has                         
been frequently used and verified (Lineberger et al, 2002; Charpentier and Oswald,                       
2004). To determine if the reporter system could be used in a more biologically relevant                             
cell line, RKO cells were selected. RKO cells are derived from a human colorectal                           
carcinoma and therefore represent a more typical environment for  E. coli, and their                         
derived OMVs (Savageau, 1983; Ahmed et al, 2013). The experiment was conducted as                         
before, and it was found that the cells were able to take up the dye, and also that the ClyA                                       
Bla reporter OMVs caused a significant change from green to blue fluorescence over 3h,                           
compared with the control OMVs and with uninfected cells (Figure 3.6). Although the                         
change in fluorescence for the cells infected with the empty vector OMVs was higher                           
than that observed in HeLa cells, which may be due to reduced dye stability, there was                               






OMV uptake (Y axis) was defined as the ratio of blue:green fluorescence in RKO cells                             
measured over 3h as an indication of entry of β­lactamase from the reporter OMV into                             
the cells, where cleavage of CCF2­AM substrate then occurred (A). Data shown are                         
means with SD, from three biological replicates with three technical replicates each.                       
Efficiency of uptake was defined as the total change over 3h and was highest in cells                               
infected with ClyA­Bla OMVs (B). A student’s T test was used to analyse results, with                             






















Methods used to isolate, quantify and characterise OMVs vary between studies. To                       
determine if this method could be used without prior isolation of OMVs, a transwell                           
experiment was conducted. Whole cultures of the ClyA Bla or empty vector strains were                           
added to transwell inserts with pores of 0.4 μm to allow passage of vesicles into the HeLa                                 
cells cultured below the inserts. These experiments were conducted over a longer time                         
period (15 hours) to allow production of OMVs from the bacterial cultures, and their                           
movement through the transwell into the cell culture. After 15 hours, there was a clear                             
difference in the blue vs green fluorescence intensity detected in the cells, suggesting                         
passage of reporter OMVs and entry into the HeLa cells without prior isolation or                           
concentration (Figure 3.7). This method can therefore be adapted for use without the time                           






Cultures of reporter and empty vector strains were added to 0.4 μm transwell inserts,                           
above cultured HeLa cells loaded with CCF2­AM. OMV uptake (Y axis) represents the                         







This chapter describes a novel assay that can be used to determine the kinetics of                             
interactions between OMVs and host cells. The affinity of OMVs for host cells during                           
infection is well established, and many bacterial factors involved in adherence to host                         
cells have been identified in OMVs (Kesty et al, 2004; Kuehn and Kesty, 2005).                           
Underpinning the bacterial and host factors involved in these processes has been made                         
more challenging by the small size of OMVs, and the need for high powered imaging or                               
electron microscopy to visualise their presence in infected tissue. It is likely that their role                             
in infections has been underestimated, as they would not be visible in typical biopsies,                           
and they can also be present in sites distant to the origin of infection (Dorward, Schwan                               
and Garon, 1991; Kuehn and Kesty, 2005; Ellis and Kuehn, 2010).  
Current methods for studying the mechanisms of OMV­mediated delivery of bacterial                     
cargo into host cells have produced inconsistent and often contradictory findings, often                       
relying on less quantitative approaches, such as membrane labelling and                   
immunofluorescence, or using changes in cytotoxicity or host cell phenotype as an                       
indicator of OMV cargo delivery. This method provides a consistent platform for further                         
studying the behaviour of OMVs in the context of infection and has overcome the                           
difficulties associated with many of these methods, by utilising a sensitive, adaptable and                         
quantifiable approach to the kinetics of OMV entry into host cells.  
 
This work has shown that OMVs which display active β­lactamase can be used as                           
reporter vesicles that indicate host cell entry through the efficient real­time cleavage of                         
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 dye molecules loaded into the host cells, removing the need for membrane or antibody                           
labelling of specific OMV proteins or lipids, which may ignore subpopulations, or                       
become very diluted when in the context of infection.  
 
Using the colour change in the host cells to detect delivery allows for more robust                             
quantification of OMV delivery, as the change in emission is readily detectable for a                           
much higher number of cells compared with quantifying individual OMVs present in a                         
host cell using selected fields of view in light microscopy. Other studies have also used                             
changes in host cell phenotype or cytotoxicity to correspond to OMV entry, but typically                           
these methods result in considerable delays in detection; this work indicates that                       
significant OMV entry occurs within 10 minutes. This also establishes that there is very                           
little lag between OMV entry and dye cleavage, making it appropriate as an indicator of                             
such rapid events. 
 
It also removes the need to fix the cells after pre­designated time points, which may miss                               
the kinetics of OMV­host cell associations and delivery. This work allows the study of                           
OMVs without altering the morphology, size or charge of the vesicles, and since ClyA is                             
naturally targeted into vesicles, the expression of the ClyA­Bla fusion protein should not                         
interfere with their behaviour. It will also potentially allow investigation and comparison                       
of OMVs from a wide range of Gram negative species, simply by expression of the                             
fusion protein, rather than relying on species­specific or unique characteristics of certain                       
OMV populations. OMVs contribute to communication and interactions between                 
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 bacterial cells, and by modification of the CCF2­AM molecule, (as bacteria do not                         
possess the esterases required to modify the dye substrate and retain it within the cell)                             
this method could also be adapted to study delivery of OMVs between bacterial cells                           
(Nord et al, 2005).  
 
This method was able to detect rapid changes in fluorescence in the host cell as result of                                 
entry of β­lactamase and cleavage of the CCF2­AM substrate. This indicated that not                         
only do OMVs enter and deliver cargo to host cells within minutes of infection, the                             
method was sensitive enough to detect this, with little or no delay. This suggests that                             
spatial or temporal separation of OMVs from the CCF2 substrate is not a limitation of the                               
assay. This method has been established in several different viral infections, where the                         
kinetics observed are very similar to those seen here. The size of viruses and OMVs can                               
overlap, and this unique approach allows for the rapid entry of these small particles to be                               
determined and quantified (Cavrois et al, 2003; Landowski et al, 2014).  
 
This method is also adaptable to high throughput analysis, and has been previously used                           
for drug screening of compounds to identify inhibition of entry of Ebola virus into HeLa                             
cells (Kouznetsova et al, 2014). The use of a plate reader in these experiments allowed                             
continuous monitoring of blue and green emission simultaneously to detect disruption of                       
FRET, without the need for any manual interference with the experiment. It allowed for                           
more robust data analysis as technical replicates could be performed and analysed in a                           
much less time consuming manner than interpretation of microscopy data. It also means                         
105 
 that several different conditions can be screened at once, through the use of the multi well                               
plate format.  
 
This method has also been used to detect delivery of OMV cargo without the need for                               
prior isolation of OMVs, by using the whole bacterial cultures in a transwell assay. This                             
removes the time consuming isolation and characterisation steps, and also provides                     
insight into the real­time dynamics of OMV release from the bacterial cell into the host.                             
This approach could help to resolve some of the contradictory findings between studies,                         
that may be due to variations in methods used to isolate, quantify and characterise                           
vesicles prior to infections experiments. 
 
Isolation methods can cause variations in the numbers of OMVs produced, so in this                           
work, OMV numbers were carefully monitored using a combination of the protein                       
content, β­lactamase activity and the nanoparticle tracking analysis to ensure the                     
concentrations in the samples were normalised prior to infection of cells. In these                         
experiments, an MOI of 1000 OMVs per HeLa cell was used, equivalent to an OMV                             
protein concentration of 10 μg/ml .  This is considerably lower than concentrations used in                         
other studies, which have used up to 200 μg/ml, and for periods of up to 24 h, compared                                   
with 3h used in these experiments (Chitcholtan et al, 2008). It was determined that an                             
average of 41 OMVs were isolated per bacterial cell for EHEC ClyA Bla, and therefore                             
this would be equivalent to a bacterial MOI of 25. This is potentially lower than a                               
physiological MOI of OMVs per cell, and so it is encouraging that a relatively low                             
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 number of OMVs is able to deliver sufficient β­lactamase to cleave the dye molecules in                             
the HeLa cells (Namork and Brandtzaeg, 2002). The entry of OMVs was detected in                           
HeLa cells, but also in the biologically relevant intestinal epithelial cell line, RKO. Other                           
cell lines including HT29 and Caco­2 intestinal epithelial cells were found to be                         
incompatible with this system, although it is unclear whether it is an issue with dye                             
uptake or dye retention. 
 
Exploring OMV entry processes will allow new insight into potential means of                       
attenuating infections by preventing OMVs delivering their toxic cargo into hosts, but                       
could also aid in the use of OMVs as designer delivery vehicles, due to their high affinity                                 
for host cells. The potential applications of OMVs in medicine and research will be                           
broadened by new understanding of their ability to enter host cells and allow exploitation                           
of these mechanisms.  
 
The next chapters will utilise the assay to determine bacterial factors which influence the                           










The previous chapter developed an assay that can detect and quantitatively measure the                         
kinetics of OMV uptake into host cells, by monitoring the change in fluorescence in host                             
cells upon delivery of β­lactamase from engineered reporter vesicles into the cell                       
cytoplasm.  
 
The role of O polysaccharide in the interactions of OMVs with host cells has not been                               
explored until now. Since OMVs are derived from the outer membrane, they contain LPS,                           
and therefore also O polysaccharide (Park et al, 2010). OMV production also appears to                           
be linked to modifications of LPS under different environmental conditions (Bonnington                     
and Kuehn, 2016). The immunogenicity of OMVs cannot be attributed to the LPS content                           
alone, as inoculation with equivalent or 2­fold higher amounts of purified LPS elicited far                           
less lethality in a sepsis model (Park et al, 2010). OMVs are around 20­200 nm in                               
diameter, but O polysaccharide alone can protrude over 30 nm (Strauss et al 2009). The O                               
polysaccharide on OMVs may therefore represent an initial point of contact between                       
OMVs and the host cell surface during infection.  
 
This chapter sought to identify whether presence or absence of O polysaccharide on                         
OMVs has an effect on their uptake by host cells. To check the correlation between LPS                               
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 and OMV uptake, OMVs with and without O polysaccharide, from different serotypes                       













4.2.1 EHEC OMVs enter host cells more rapidly and efficiently than OMVs from E. coli                             
K12. 
OMVs were isolated from EHEC and K12 ClyA­Bla strains. The number of OMVs was                           
measured using Nanosight nanoparticle tracking analysis, with an average concentration                   
of 1.1 x10 12  OMVs per ml for EHEC, and 1.96 x 10 11  OMVs per ml for K12 (Figure                                   
4.1A). This is in accordance with other data indicating that pathogenic strains can release                           
up to 10 fold more OMVs than non­pathogenic strains (Horstmann and Kuehn, 2000).                         
The mean protein concentration in EHEC OMV samples was 86 +/­ 11μg/ml, and 14 +/­                             
3 μg/ml for K12 .  EHEC OMVs were significantly smaller than K12 OMVs. The average                           
diameter was 79 +/­ 35 nm for EHEC, and 86 +/­ 38 nm for K12 (Figure 4.1B). The                                   
median sizes were 75 nm for EHEC, and 86 nm for K12 (Figure 4.1B). Prior to use in                                   
infection experiments, the OMV concentrations were normalised by diluting EHEC                   
OMVs 6 fold to be equivalent to K12. The protein concentration was measured after                           
normalisation and was found to be 15 μg/ml. 50 μl of normalised samples were added to                               
nitrocefin, which is hydrolysed in the presence of β­lactamase, resulting in a colour                         
change from yellow to red, to determine the specific β­lactamase activity. After                       
normalising the number of OMVs in the samples, the β­lactamase activity was equivalent                         
(Figure 4.1C).  
 
HeLa cells infected with reporter OMVs from EHEC showed a higher and faster change                           
in blue:green fluorescence intensity ratio (representing exposure of the OMV­derived                   
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 ClyA Bla probe to the CCF2­AM FRET substrate in the cytoplasm) after 3h compared                           
with cells infected with reporter OMVs from  E. coli K12 (Figure 4.2A). The change in                             
gradient was estimated (Figure 4.2B) and there was a higher maximum rate of change                           
from green to blue (Figure 4.2C) and a significantly higher total change in the blue:green                             
fluorescence intensity ratio for cells infected with EHEC OMVs (Figure 4.2D). This                       
indicated a higher rate and efficiency of uptake of EHEC OMVs compared with OMVs                           
from  E. coli K12.  
 
These differences were independent of OMV concentration and β­lactamase activity                   
which were equivalent for both strains (Figure 4.1C). Protein concentration in OMV                       
samples was measured, and 5, 10 and 20 μg/ml were tested in the infection experiments.                             
The efficiency of uptake of OMVs increased when the concentration was increased from                         
5 μg/ml to 10 μg/ml, but the maximum rate appeared to stop increasing at 20 μg/ml for                                 
EHEC, suggesting a partial concentration dependency but a possible saturation of entry                       
mechanisms above this level (Figure 4.3A, B). For K12, the maximum rate appeared to                           
continue to increase (Figure 4.3B) 
 










The concentration and diameter of OMVs was measured with Nanoparticle tracking                     
analysis (A, B) for two biological replicates and three technical replicates with a                         
minimum of 100 tracks. EHEC released more OMVs than K12 (A) with an average                           
concentration of 1.1 x10 12 OMVs per ml for EHEC, and 1.96 x 10 11 OMVs per ml for                                 
K12. Error bars represent standard deviation. The mean protein concentration in EHEC                       
OMV samples was 86 +/­ 11 μg/ml, and  14 +/­ 3 μg/ml for K12. Student’s T test                                 
determined EHEC OMVs were significantly smaller than K12 OMVs, p < 0.05 (*) (B)                           
Black lines represent mean size values (79 +/­ 35 nm for EHEC, and 86 +/­ 38 nm for                                   
K12). The concentrations of OMVs were normalised, and β­lactamase activity was                     
determined. Normalised samples showed equivalent β­lactamase activity, calculated by                 
ability to hydrolyse nitrocefin (C). Data shown are means of three technical replicates for                           




 Figure 4.2. EHEC OMVs enter host cells more rapidly and efficiently than OMVs from                           
E. coli K12.  
OMV uptake (Y axis) was defined as the ratio of blue:green fluorescence intensity in                           
HeLa cells infected with reporter OMVs from EHEC and K12 measured over 3h (A) This                             
was normalised, with the fluorescence in uninfected cells used as a baseline, and data at                             
0h normalised to zero. The gradient over time (rate) was then estimated (B) to calculate                             
the maximum rate of uptake (D). The total change in blue:green over 3h (efficiency of                             
uptake) was significantly higher in cells infected with EHEC reporter OMVS compared                       
with cells infected with reporter OMVs from K12 (C). Student’s t­test was used to                           
compare samples, which were from three biological replicates with three technical                     
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Increased OMV concentration (from 5 μg/ml­20 μg/ml) increased uptake, but the                     
maximum rate of uptake appeared to saturate above 10 μg/ml (A, B) for EHEC (red),                             
whilst the efficiency of uptake did not saturate for either EHEC (red) or K12 (blue) (B).                               








Since OMVs are derived from the outer membrane of Gram negative bacteria, they                         
contain lipopolysaccharides (LPS), (Cahill et al, 2015). Whilst lipid A and the core                         
oligosaccharide regions are well conserved, many species including EHEC contain a                     
highly variable polysaccharide domain known as O polysaccharide (Strauss et al, 2009).                       
The O polysaccharide constitutes the outermost region of LPS, and due to its length of up                               
to 30 nm (Strauss et al, 2009), likely the first component in contact with host cells. These                                 
characteristics led to the hypothesis that the O polysaccharide moiety present on EHEC                         
OMVs may be a determinant for OMV recognition and uptake by host cells. 
 
To test this hypothesis, FRET assays were carried out with Hela cells exposed to                           
ClyA­Bla reporter OMVs harvested from three pairs of strains, reflecting different  E. coli                         
serotypes and pathovars and O polysaccharide deficient isogenic mutants, to determine                     
how the presence or absence of O polysaccharide would impact OMV uptake kinetics in                           
each case.  
 
OMVs were derived from two pathogenic strains of  E. coli , EHEC (serotype O157) Sakai                           
and enteroaggregative  E. coli  (EAEC, serotype O42), and from the non­pathogenic K12                       
lab strain MG1655 (serotype O16). Prior to infection, OMVs were analysed for their size,                           
concentration and surface charge (Figure 4.4A­C). The average size of EHEC OMVs                       
with O polysaccharide was 79 +/­ 36 nm vs 76 +/­ 35 nm for those without O                                 
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 polysaccharide. For K12, the average size for O polysaccharide OMVs was 91 +/­ 34 nm                             
vs 86 +/­ 39 nm for O polysaccharide­lacking OMVs. There were no significant                         
differences between the size or concentration of OMVs with or without O polysaccharide                         
for EHEC or K12, although O polysaccharide positive strains produced more OMVs: 1.1                         
x10 12 particles per ml and 5.3 x10 11 particles per ml for EHEC, 2.7 x10 11 particles per ml                                 
and 1.9 x10 11 particles per ml for K12. In contrast, EAEC OMVs lacking O                           
polysaccharide were significantly smaller than the O42 counterparts: the average size of                       
OMVs with O polysaccharide was 102 nm, compared with 74 nm for OMVs without O                             
polysaccharide (Figure 4.4A). OMVs lacking O polysaccharide also had a significantly                     
higher concentration: 8.7 x10 11 particles per ml, compared with 1.5 x10 11 particles per ml                           
for O polysaccharide OMVs (Figure 4.4B). Surface charge was measured using Zeta                       
analysis. Presence of O polysaccharide for K12 and EHEC resulted in reduced negative                         
charge, but for EAEC, the presence of O polysaccharide increased the negative charge of                           





Isolated OMVs were diluted 1x10 ­6 and nanoparticle tracking analysis was used to                       
determine the size distribution (A) and concentration with error bars showing standard                       
deviation (B). Black lines in (A) represent median size from at least 100 tracks acquired                             
per sample. Statistical significance was determined by Student’s t­test, between OMV                     
samples with or without O polysaccharide, with 6 technical replicates treated                     
independently. EAEC OMVs without O polysaccharide were significantly smaller than                   







 The OMV concentration was normalised using the nanosight data, and OMVs were                       
added to HeLa cells at an MOI of 1000 OMVs/host cell. The change in fluorescence from                               
green to blue was measured over 3h as an indicator of OMV uptake. For EHEC, OMVs                               
from EHEC O157 wild type cells and an isogenic strain lacking the O157 O                           
polysaccharide (gne::IS629) were compared (Rump et al, 2010). The O polysaccharide                     
deficient mutant gne::IS629 carries a 1310 bp insertion in  gne , disrupting the epimerase                         
required for synthesis of the oligosaccharide repeating unit in the O polysaccharide                       
(Figure 1.2, Rush et al, 2010; Rump et al, 2010). The maximum rate of uptake for                               
ClyA­Bla reporter OMVs derived from this O polysaccharide deficient EHEC strain and                       
the isogenic wild type O157 strain were not significantly different (Figure 4.5C).                       
However, OMVs derived from wild type EHEC with intact O polysaccharide sustained a                         
higher entry rate over a longer period (Figure 4.5B), and thus entered host cells ~ 43%                               






Figure 4.5. Presence of O polysaccharide increases efficiency of uptake of OMVs from                         
EHEC. 
CCF2­AM loaded Hela cells were exposed to ClyA­Bla OMVs isolated from EHEC                       
containing O polysaccharide (red), or lacking O polysaccharide (blue) at an MOI of                         
1000 for 3 hours. OMV uptake (Y axis) is defined as the ratio of blue:green fluorescence                               
over 3h as an indication of entry of β­lactamase from the reporter OMVs into host cells,                               
where cleavage of CCF2­AM substrate then occurred (A). Data shown are means with                         
SD, with three technical replicates for each of three separate experiments. The gradient                         
of the colour change was estimated to determine rate of colour change over time (B) and                               
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 (Figure 4.5 continued)...the maximum rate of change was determined as the highest                       
change in gradient over the 3h (C). Efficiency of uptake (D) was defined as the total                               
change in blue:green ratio over 3h from (A). ANOVA was used to analyse results, with a                               
Brown Forsythe test for equal variance. Replicates were treated as 9 independent                       
replicates, and corrected for multiple comparisons between samples. A p value < 0.05                         
was considered significant (*) and p > 0.05 was not considered statistically significant                         




OMVs from wild type EAEC (serotype O42, intact O polysaccharide) were compared                       
with OMVs from an isogenic O polysaccharide deficient mutant (∆ wbaC , lacking a                       
glycosyltransferase necessary for O polysaccharide synthesis; Figure 1.2, Browning et al,                     
2013). EAEC OMVs with intact O polysaccharide entered host cells ~66% more                       
efficiently than OMVs without O polysaccharide, due to a 77% higher maximum rate of                           
uptake (Figure 4.6A­D) and a higher sustained rate over time (Figure 4.6B). This was in                             





 Figure 4.6. Presence of O polysaccharide increases rate of uptake of OMVs from                         
EAEC. 
CCF2­AM loaded Hela cells were exposed to ClyA­Bla OMVs isolated from EAEC                       
containing O polysaccharide (red), or lacking O polysaccharide (blue) at an MOI of                         
1000 for 3 hours. OMV uptake (Y axis) is defined as the ratio of blue:green fluorescence                               
over 3h as an indication of entry of β­lactamase from the reporter OMVs into host cells,                               
where cleavage of CCF2­AM substrate then occurred (A). Data shown are means with                         
SD, with three technical replicates for each of three separate experiments. The gradient                         
of the colour change was estimated to determine rate of colour change over time (B) and                               
the maximum rate of change was determined as the highest change in gradient over the                             
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 (Figure 4.6 continued)...3h (C). Efficiency of uptake (D) was defined as the total change                           
in blue:green ratio over 3h from (A). ANOVA was used to analyse results, with a Brown                               
Forsythe test for equal variance. Replicates were treated as 9 independent replicates, and                         




The non­pathogenic laboratory strain  E. coli K12 MG1655 has lost its ability to produce                           
O polysaccharide due to a disruption in  wbbL encoding the rhamnosyltransferase required                       
for O polysaccharide synthesis (Figure 1.2, Liu and Reeves, 1994). These experiments                       
compared entry of OMVs from this O polysaccharide deficient strain, to those from an                           
isogenic strain (DFB 1655 L9), where wild type  wbbL has been restored, allowing                         
expression of the strain’s original O16 O polysaccharide (Browning et al, 2013) (Figure                         
4.7A). Similar to O157, the presence or absence of O polysaccharide did not significantly                           
alter the maximum rate (Figure 4.7C) but the presence of O polysaccharide allowed for a                             
higher rate to be sustained for longer (Figure 4.7B), leading to a ~ 22% higher efficiency                               
of OMV uptake overall (Figure 4.7D).  
 
Taken together, these results suggest that the presence of the LPS O polysaccharide                         
increases the entry efficiency of OMVs into host cells, independent of the specific                         
mutation leading to O polysaccharide deficiency. Depending on the serotype used, this is                         
caused by enhancing the maximum rate and/or by sustaining a higher uptake rate over a                             
longer period, compared to OMVs lacking O polysaccharide. These variations may be                       
due to differences in physicochemical features and/or other vesicle cargos between the                       
different serotypes. 
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 Figure 4.7. Presence of O polysaccharide increases efficiency of uptake of OMVs from                         
K12 
CCF2­AM loaded Hela cells were exposed to ClyA­Bla OMVs isolated from EAEC                       
containing O polysaccharide (red), or lacking O polysaccharide (blue) at an MOI of                         
1000 for 3 hours. OMV uptake (Y axis) is defined as the ratio of blue:green fluorescence                               
over 3h as an indication of entry of β­lactamase from the reporter OMVs into host cells,                               
where cleavage of CCF2­AM substrate then occurred (A). Data shown are means with                         
SD, with three technical replicates for each of three separate experiments. The gradient                         
of the colour change was estimated to determine rate of colour change over time (B) and                               
the maximum rate of change was determined as the highest change in gradient over the                             
3h (C). Efficiency of uptake (D) was defined as the total change in blue:green ratio over                               
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 (Figure 4.7 continued)...3h from (A). ANOVA was used to analyse results, with a Brown                           
Forsythe test for equal variance. Replicates were treated as 9 independent replicates, and                         





The previous experiments determined that presence of O polysaccharide can increase                     
either the rate or the overall efficiency of OMV uptake in HeLa cells. Pathogenic  E. coli                               
strains are able to colonise the intestinal epithelium, and O polysaccharide has previously                         
been implicated in contributing to this process (Ho and Waldor, 2007; Sheng et al, 2008).                             
Conducting these FRET assays in an intestinal epithelial cell line is therefore more                         
biologically relevant. For this reason, the experiments were repeated in RKO cells, a                         
rectal carcinoma cell line (Ahmed et al, 2013).  
 
As observed in HeLa cells, the OMVs with O polysaccharide showed more efficient entry                           
and disruption to FRET in RKO cells (Figure 4.8A­D). This was the case for OMVs for                               
EHEC, EAEC and K12. Whilst the overall fluorescence was lower than detected in HeLa                           
cells (Figure 4.8A­C), which may be due to a difference in the ability of esterases within                               
the cell to allow retention of the dye, the general effect was the same as for HeLa cells;                                   






 Figure 4.8. O polysaccharide increases efficiency of OMV uptake by intestinal                     
epithelial cells. 
CCF2­AM loaded RKO cells were exposed to ClyA­Bla OMVs isolated from EHEC (A),                         
EAEC (B) or K12 (C) containing O polysaccharide (red), or lacking O polysaccharide                         
(blue), at an MOI of 1000 for 3 hours. OMV uptake (Y axis) was defined as the ratios of                                     
blue:green fluorescence over time, representing cleavage of CCF2­AM substrate by OMV                     
cargo within RKO cells. Ratios (A­C) were plotted as means ± stdev (n=3).Total FRET                           







Interactions between bacterial outer membrane vesicles and epithelial cells are now                     
recognized as an important driver of bacterial pathogenesis. Yet, the ability to study                         
vesicle­host cell interactions has been limited by a lack of methods to capture the rapid                             
kinetics of vesicle entry and dismantling in real­time, and without altering the                       
physicochemical properties of the vesicle. The assay developed here fulfils these                     
requirements and allowed the study of the kinetics of OMV uptake with enough temporal                           
resolution to reveal critical differences in rate and uptake efficiency of vesicles derived                         
from different  E. coli serotypes and pathovars.  
 
The method uses a genetically encoded, OMV targeted probe and a cell­permeable dye,                         
resulting in a change in FRET upon reporter uptake and dye cleavage. An advantage of                             
this system is its high sensitivity, as 5 µg/ml OMVs, the lowest concentration reported in                             
the literature, produced a reproducible trace with good signal/noise ratio. A rapid                       
response was detected with this method, as changes in the fluorescence signal were                         
detected within seconds. The use of this system can be extended to a high­throughput                           
format, allowing further study of bacterial and host factors determining OMV uptake and                         
trafficking. Using a transwell format, the method can be applied to cell­based assays                         
consisting of bacteria releasing OMVs, and host cells without the need for OMV                         
isolation. Although the specific probe used here was functional across a range of  E. coli                             
isolates and different host cell types, its use in other bacterial species will require further                             
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 characterization to determine if it is correctly targeted to OMVs and remains                       
enzymatically active.  
 
EHEC and EAEC OMVs were selected for this study, since OMVs have been shown to                             
play a crucial role in toxin stabilization and delivery for both species and have been                             
considered as a means to vaccinate and protect against hemolytic uremic syndrome, a                         
severe complication of EHEC infection (Aldick et al, 2008; Choi et al, 2014; Kunsmann                           
et al, 2015). It is clear that LPS, and specifically O polysaccharide, contributes to                           
bacterial fitness within a host and pathogenicity, by enhancing resistance to complement,                       
modulating phagocytosis and phage infection (Liang­Takasaki et al, 1982; Van der Ley et                         
al, 1986). The O polysaccharide of most  E. coli  strains has 10­18 repeats, whilst EHEC                             
O157 can exceed 80 repeats (Franco, Liu and Reeves, 1998; Kalynych et al, 2011). The                             
length of the O polysaccharide in EHEC can be over 30 nm, with the length of the O                                   
polysaccharide positively correlated with the ability of the bacterial cell to adhere to host                           
cells and tissues, while loss of O polysaccharide results in defects in colonisation, biofilm                           
formation, and increased pathogen clearance (Murray, Attridge and Morona, 2006; Sheng                     
et al, 2008; Strauss et al, 2009; Hathroubi et al, 2016). It is compelling that many lab                                 
strains lose their O polysaccharide, suggesting an advantage in survival in natural settings                         
that is lost in an artificial growth conditions (Stevenson et al, 1994). 
 
Studies into the contribution of O polysaccharide to bacterial fitness have typically                       
focused on whole bacterial cells, while comparatively little research has been conducted                       
128 
 into its possible role in the behaviour of OMVs, and their affinity for host cells. Recent                               
work showed that EHEC OMVs allow efficient delivery of LPS into the host cell                           
cytoplasm, resulting in inflammatory responses, caspase­11 activation and cell death, but                     
did not explore the role of LPS in uptake (Kunsmann et al, 2015; Vanaja et al, 2016).                                 
Other work has suggested that modifications to the composition of the LPS can increase                           
the production of OMVs in order to increase survival during unfavourable conditions,                       
such as low pH (Bonnington and Kuehn, 2016). This data suggest that O polysaccharide                           
has an additional role during bacteria­host interactions, which is to accelerate the uptake                         
and delivery of vesicle associated virulence factors such as hemolysins and Shiga­like                       
toxins to host cells and enhancing pathogenicity (Bielaszewska et al, 2017).  
 
For EHEC and K12, presence of O polysaccharide did not have a significant effect on                             
production of OMVs, but for EAEC the absence of O polysaccharide resulted in a                           
significant increase in the concentration of OMVs isolated. Unlike K12 and EHEC, the                         
presence of O polysaccharide resulted in a more negative surface charge. EAEC                       
expresses fimbriae at the outer surface which enhance aggregation. The fimbriae are                       
highly positively charged, therefore without the O polysaccharide the membrane may                     
have become more positively charged, and this may have affected membrane stability and                         
OMV production, and also the interaction of the OMVs with the host. In the other strains,                               
the opposite was true, as since the O polysaccharide is generally un charged, its presence                             
can reduce the overall negative charge of the membrane. The largest change in rate of                             
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 uptake was observed for the EAEC OMVs, and so it may be that the effect of the O                                   
polysaccharide is more significant in this strain. 
 
A limitation of this work is that all three mutants used were constructed differently, as the                               
genes to synthesise O polysaccharides vary. As complementations of the mutants were                       
not used, it is possible that these deletions have other effects that were not controlled for                               
and this may alter the OMV cargo and behaviour. It would be necessary to use OMVs                               
from complemented strains in the future, and also to express the same O polysaccharide                           
in all three to control for variations in the O polysaccharide structure affecting their                           
ability to enter cells. 
 
HeLa cells were primarily used in this work, as they are well established for use with the                                 
CCF2 substrate, as well as infection studies, but the same effect was also observed in the                               
rectal carcinoma cell line, RKO. These cells are more relevant to the study of  E. coli                               
pathogenesis, which typically occurs in the intestine, and so it is encouraging that the                           
results were replicated in these cells. Other intestinal cell lines, such as HT29, were also                             
investigated, but preliminary experiments showed that they were unable to retain the                       
CCF2­AM substrate. Zebrafish embryos were also injected with the substrate, but no dye                         
uptake was observed, even at a 10 fold higher concentration of the substrate. This may be                               
due to differences in esterase activity, which is required to decrease the hydrophobicity of                           
the FRET probe, thus decreasing its membrane permeability and trapping the probe in the                           
host cell cytoplasm. Whilst it is disappointing that this system did not work in a zebrafish                               
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 model, it still represents a useful high throughput approach to studying kinetics of vesicle                           
entry into host cells in tissue culture. In the future, this format could be used to identify                                 
particular chemicals or treatments which impair the ability of OMVs to enter host cells.                           
Since OMVs are able to deliver toxic cargo and promote pathogenesis, inhibition of their                           
entry and cargo delivery may become a useful means of attenuating infection. In contrast,                           
it could also be used to find molecules or receptors which enhance delivery, and facilitate                             
the development of ‘designer vesicles’ which could deliver molecules such as dyes or                         
drugs to specific cells.  
 
It is well known that OMVs contain different cargos, depending on pathovar and serotype                           
(Bonnington and Kuehn, 2016). OMVs are a dynamic form of export from the bacterial                           
cell, and their cargo reflects the needs of their cell of origin, and therefore varies with                               
growth phase, environmental conditions and stress responses (McBroom and Kuehn,                   
2007). OMVs are able to transport a wide variety of cargo molecules from the bacterial                             
cell into its external environment, and thus the roles that OMVs have in enhancing                           
bacterial fitness are equally diverse (Haurat et al, 2015). OMVs from K12 with restored                           
O polysaccharide were able to enter host cells and deliver their cargo more efficiently                           
than their ‘rough’ counterparts. However, the speed and efficiency of this process was                         
still lower than that observed with OMVs from the pathogenic strains of EHEC or EAEC,                             
suggesting that there are likely to be other adaptations that maximise the OMV­host cell                           
interactions during infection, or this may be due to differences in the O polysaccharide                           
structure. Although all strains used are from  E. coli , there are significant genetic                         
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 differences between the strains, and they have also adapted to different environments.                       
K12 has been a lab strain for almost 100 years, whilst EHEC is a serious human pathogen                                 
rarely found in healthy people, and EAEC is able to persist and colonise the human                             
intestinal tract. It would therefore be expected that OMVs from non pathogenic strains                         
would be less efficient at entering host cells. It is intriguing that O polysaccharide is able                               
to contribute to this process across all three strains studied.  
 
In order to try and ensure the OMV cargo was the same between the ‘rough’ and                               
‘smooth’ OMVs, it was attempted to deplete the O polysaccharide using glycoside                       
hydrolases to cleave the bonds between subunits. When the LPS of the enzyme treated                           
strains was analysed using silver staining, it was apparent that the core regions of the                             
outer membrane had also been modified, and the number of repeat units of O                           
polysaccharide, and thus it would not be a fair comparison: however future work may                           
enable characterisation of these ‘semi­rough’ OMVs in order to further elaborate on the                         
requirement of the O polysaccharide for efficient uptake of OMVs. Other studies have                         
found that even a single O polysaccharide unit can enhance virulence 100 fold compared                           
to a complete ‘rough’ strain, and so it would be interesting to determine the minimum                             
amount of O polysaccharide necessary (Bengoechea et al, 2004).  
 
All three strains used have different O polysaccharide serotypes; O16, O157 or O42. It                           
may be that the particular sugar composition alters the affinity for host cells, or that                             
strains express more or less repeats altering the interaction kinetics. It is interesting that                           
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 presence of O polysaccharide did not affect all strains in the same manner; for EHEC and                               
K12, the maximum rate was not significantly affected, but for EAEC, there was a                           
significant increase in the maximum rate, leading to an overall increase in uptake                         
efficiency. Therefore other differences in either the cargo or the membrane composition                       
may also be contributing to the ability of OMVs to enter cells. It would be useful to                                 
express the same O polysaccharide in all three strains to examine the role of the specific                               
structure in interactions with host cells, but due to the large number of unique genes in                               
the O polysaccharide synthesis operon required for expression of O polysaccharides, it                       
was experimentally difficult to transfer these genes into other strains. It would also be                           
difficult to control the number of repeats added to each O polysaccharide, which may also                             
affect its ability to interact with the host cell surface; a longer O polysaccharide may                             
result in more rapid internalisation.  
 
Previous work has indicated that the cargo of OMVs can play a role in facilitating entry,                               
and whilst this is certainly likely to be the case for many virulence factors or adhesins,                               
this work has identified a generic component of OMVs that can contribute to OMV                           
interactions with host cells, even in non­pathogenic strains. 
 
The comparison of O polysaccharide deficient mutants with wild type OMVs as well as                           
comparison of different pathovars has the pitfall that other vesicle cargo may be                         
modulated and alter uptake kinetics. However, in this study there is a reproducible                         
correlation between O polysaccharide containing and –lacking strains, across three                   
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 different serotypes and pathovars, suggesting for the first time that O polysaccharide is, if                           
not the only factor, at least a main driver of uptake kinetics.  
 
The next area to be explored in this work is unravelling how exactly the O polysaccharide                               









Previous chapters used a new and sensitive OMV uptake assay to reveal a role for O                               
polysaccharide in enhancing the ability of OMVs to enter host cells, either by increasing                           
the overall efficiency of uptake, or significantly increasing the maximum rate. This                       
occurred for OMVs derived from pathogenic strains, EHEC and EAEC but also the                         
laboratory strain, K12.  
 
This chapter utilised chemical inhibition of endocytic uptake processes to determine how                       
















Dynamin is a 100 kDa GTPase protein that facilitates invagination of the plasma                         
membrane, by polymerising around the neck of a vesicle, allowing it to pinch off and                             
become separated from the membrane (El­Sayed and Harashima, 2013; Preta et al, 2015).                         
Dynamin activity is required for both clathrin and caveolin mediated endocytosis                     
(El­Sayed and Harashima, 2013).  
 
HeLa cells pre­treated with 80 μM of the dynamin GTPase inhibitor Dynasore (Girard et                           
al, 2011; Preta et al, 2016) for 1h prior to infection with reporter OMVs from EHEC,                               
EAEC and K12 showed reduced blue fluorescence compared with untreated infected                     
cells, indicating an impairment of OMV entry and subsequent  β ­lactamase cleavage of                       
the CCF2­AM substrate (Figure 5.1A­E). This impairment occurred for OMVs with and                       
without O polysaccharide, and for the pathogenic strains EHEC and EAEC, and the                         




HeLa cells pre­treated with 80 μM dynasore for 1h prior to incubation with reporter                           
OMVs from EHEC, EAEC and K12 at an MOI of 1000 all showed a reduction in OMV                                 
uptake (A­E, grey line) compared with the untreated controls (A­E, red: presence of O                           
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 (Figure 5.1 continued) ..antigen, blue: lacking O polysaccharide). OMV uptake (Y axis)                       
was defined as the ratio of blue:green fluorescence over 3h as an indication of entry of                               
β­lactamase from the reporter OMVs into host cells, where cleavage of CCF2­AM                       





Macropinocytosis has been suggested as a possible entry mechanism for extracellular                     
vesicles into host cells (Bomberger et al, 2009). Inhibition of macropinocytosis following                       
treatment of host cells with 20 μM blebbistatin (Ramanathan et al, 2015) to inhibit the                             
formation of macropinosomes enhanced the efficiency of uptake of EHEC OMVs                     
containing O polysaccharide, but had no effect on the maximum rate of uptake (Figure                           
5.1A­D). There was no effect on uptake for EHEC OMVs without O polysaccharide                         
(Figure 5.2E­H). For EAEC, there was no effect on either the efficiency or the rate, for                               
OMVs with and without O polysaccharide (Figure 5.3).  
 
In contrast, for K12 there was a significant increase in efficiency and rate of uptake of                               
OMVs, particularly for those without O polysaccharide (Figure 5.4). This indicates that                       
inhibition of macropinocytosis causes these OMVs to use an alternative, faster pathway.  
These data suggest that only a small fraction of OMVs usually enters cells by                           







 (Figure 5.2. continued) ...HeLa cells treated with 20 μM blebbistatin for                     
macropinocytosis inhibition (orange) for 1h at 37 °C and exposed to ClyA­Bla OMVs                         
isolated from EHEC with O polysaccharide (red) or without (blue) at an MOI of 1000 for                               
3 hours. OMV uptake (Y axis) is defined as the ratio of blue:green fluorescence over 3h                               
as an indication of entry of β­lactamase from the reporter OMVs into host cells, where                             
cleavage of CCF2­AM substrate then occurred. Ratios were plotted as means ± stdev for                           
3 biological replicates with three technical replicates. (A, E) The gradient of the colour                           
change was estimated to determine the rate of colour change over time (B, F) and the                               
maximum rate of change was determined as the highest change in gradient over the 3h                             
(C, G). Efficiency of uptake (D, H) was defined as the total change in blue:green ratio                               
over 3h from (A and E). Replicates were treated as 9 independent replicates.                         







 (Figure 5.3. continued) HeLa cells treated with 20 μM blebbistatin for macropinocytosis                       
inhibition (orange) for 1h at 37 °C and exposed to ClyA­Bla OMVs isolated from EAEC                             
with O polysaccharide (red) or without (blue) at an MOI of 1000 for 3 hours. OMV                               
uptake (Y axis) is defined as the ratio of blue:green fluorescence over 3h as an indication                               
of entry of β­lactamase from the reporter OMVs into host cells, where cleavage of                           
CCF2­AM substrate then occurred. Ratios were plotted as means ± stdev for 3 biological                           
replicates with three technical replicates. (A, E) The gradient of the colour change was                           
estimated to determine the rate of colour change over time (B, F) and the maximum rate                               
of change was determined as the highest change in gradient over the 3h (C, G).                             
Efficiency of uptake (D, H) was defined as the total change in blue:green ratio over 3h                               
from (A and E). Replicates were treated as 9 independent replicates. Significance was                         







 (Figure 5.4 continued)...HeLa cells treated with 20 μM blebbistatin for macropinocytosis                     
inhibition (orange) for 1h at 37 °C and exposed to ClyA­Bla OMVs isolated from K12                             
with O polysaccharide (red) or without (blue) at an MOI of 1000 for 3 hours. OMV                               
uptake (Y axis) is defined as the ratio of blue:green fluorescence over 3h as an indication                               
of entry of β­lactamase from the reporter OMVs into host cells, where cleavage of                           
CCF2­AM substrate then occurred. Ratios were plotted as means ± stdev for 3 biological                           
replicates with three technical replicates. (A, E) The gradient of the colour change was                           
estimated to determine the rate of colour change over time (B, F) and the maximum rate                               
of change was determined as the highest change in gradient over the 3h (C, G).                             
Efficiency of uptake (D, H) was defined as the total change in blue:green ratio over 3h                               
from (A and E). Replicates were treated as 9 independent replicates. Significance was                         




The previous experiments revealed the dynamin dependent entry of OMVs into host                       
cells, but since dynamin is implicated in numerous uptake routes, it was necessary to                           
further elucidate the mechanisms of vesicle entry (Preta et al, 2015). Clathrin mediated                         
endocytosis has been described previously as a route of entry for OMVs (Olofsson et al,                             
2014). It was next determined whether the entry of OMVs was dependent on clathrin                           
mediated endocytosis, which requires dynamin and utilises protein receptors on the host                       
cell surface (Vercauteren et al, 2010).  
 
Clathrin or receptor mediated endocytosis was inhibited either by proteolytic removal of                       
all protein receptors from the surface of HeLa cells with 5μg/ml papain prior to                           
incubation with OMVs, or by blocking clathrin­coated pit assembly using 1μg/ml                     
chlorpromazine (Larrick et al, 1985; Papatheodorou et al, 2010; Vercauteren et al, 2010).                         
Removal of protein receptors from the host cell surface had no effect on the efficiency of                               
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 uptake for OMVs with O polysaccharide, for EHEC, EAEC and K12 but significantly                         
decreased efficiency of uptake of O polysaccharide deficient OMVs, particularly for K12                       
(Figure 5.5). Pre­treatment of cells with chlorpromazine had a similar effect; but                       
significantly increased the overall uptake for EHEC and K12 OMVs with O                       
polysaccharide (Figure 5.5).  
 
Treatment with papain did not alter the maximum rate of uptake for EHEC or EAEC                             
OMVs, but caused a significant increase in rate for K12 OMVs with O polysaccharide,                           
and additionally a significant decrease in rate of uptake for those without O                         
polysaccharide (Figure 5.6). Similarly, chlorpromazine treatment did not affect the                   
maximum rate for EHEC or EAEC OMV uptake, but again caused a significantly                         
increased rate of uptake for OMVs from K12 with O polysaccharide (Figure 5.6). Both                           
papain and chlorpromazine negatively affected uptake of OMVs without O                   
polysaccharide, and although produced variable effects in O polysaccharide positive                   
OMVs, they did not inhibit uptake. 
 
This suggests that OMVs lacking O polysaccharide require protein receptors for uptake                       
and use clathrin­mediated endocytosis as a main route of entry. In contrast, OMVs with                           






Figure 5.5. OMVs lacking O polysaccharide require clathrin mediated endocytosis for                     
entry into host cells. 
Hela cells were either left untreated (control, red), or pre­treated with 5 µg/ml papain                           
(lilac), 1 µg/ml chlorpromazine (pink) and exposed to ClyA­Bla OMVs isolated from                       
EHEC (A), EAEC (D) or K12 (G) with (red) or without (blue) O polysaccharide at an                               
MOI of 1000 for 3 hours. OMV uptake (Y axis) is defined as the ratio of blue:green                                 
fluorescence over 3h as an indication of entry of β­lactamase from the reporter OMVs                           
into host cells, where cleavage of CCF2­AM substrate then occurred. Ratios were plotted                         
as means ± stdev for 3 biological replicates with three technical replicates.                       
(A,B,D,E,G,H). Efficiency of uptake (C, F, I) was defined as the total change in                           
blue:green ratio over 3h from (A,B,D,E,G,H). ANOVA was used to analyse results, with a                           
Brown Forsythe test for equal variance. Replicates were treated as 9 independent                       
replicates, and corrected for multiple comparisons between samples. P value < 0.05 was                         






Figure 5.6. Rate of entry for OMVs with O polysaccharide increases in the absence of                             
clathrin mediated endocytosis. 
To determine rate of OMV entry, polynomials were fitted to each FRET data set in Figure                               
5.5 (A,B,D,E,G,H) using the cubic spline function csaps in Matlab. Numerical estimates                       
of the gradients of the resulting polynomials were determined using the gradient function.                         
Data shown are means ± stdev for 3 biological replicates with three technical replicates.                           
Maximum rate of uptake (C, F and I) were determined from data in ( A,B,D,E,G,H ) as the                               
maximum change in gradient over 3h. Data shown are means ± stdev, with replicates                           
treated as 9 independent replicates. Significance was determined by ANOVA, with a                       
Brown Forsythe test to determine equal variance, and corrected for multiple comparisons                       
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 (Figure 5.6 continued)...between samples and with their relevant control. A p value <                         




5.2.4 OMVs with O polysaccharide enter host cells faster because they can access                         
raft­mediated endocytosis more efficiently. 
Since OMVs displaying O polysaccharide on their surface accessed host cells faster in                         
the absence of clathrin­dependent endocytosis, it seemed that they were not dependent on                         
this route and must be using an alternative entry pathway. The next experiments                         
investigated whether this was mediated by raft­dependent pathways, which use                   
cholesterol rich microdomains of the plasma membrane, and in the case of caveolin                         
mediated entry, also require dynamin (Rewatkar et al, 2015). Disruption of raft­mediated                       
endocytosis, either by sequestration of membrane cholesterol from membrane                 
microdomains via methyl­β­cyclodextrin (mbcd) (Danthi and Chow, 2004; Vercauteren et                   
al, 2010; Contreras et al, 2010) or by disrupting raft dynamics with filipin (Maxfield and                             
Wustner, 2012; Ilnytska et al, 2013) led to a reduced r max (Figure 5.8) and uptake                             
efficiency (Figure 5.8).  
 
For EHEC OMVs, efficiency of uptake was reduced in the absence of lipid rafts,                           
irrespective of the presence of O polysaccharide, but this effect was more pronounced for                           
the OMVs containing O polysaccharide (Figure 5.7 A­C). However, the maximum rate of                         
uptake was significantly reduced for EHEC O polysaccharide OMVs, whereas the                     
maximum rate of uptake was unaffected for the OMVs lacking O polysaccharide (Figure                         
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 5.8 A­C). This suggests that the EHEC OMVs with O polysaccharide are more adversely                           
affected by the loss of lipid rafts as an entry pathway than their non­O polysaccharide                             
counterparts. 
 
For EAEC OMVs, the efficiency of uptake was significantly reduced by filipin, but only                           
the O polysaccharide negative OMVs were significantly inhibited by mbcd (Figure 5.7                       
D­F). The maximum rate was not affected for either O polysaccharide or non­O                         
polysaccharide OMVs (Figure 5.8 D­F). The effect of filipin treatment was more                       
significant on the O polysaccharide containing OMVs.  
 
In the case of K12 OMVs, mbcd did not reduce efficiency of uptake for the O                               
polysaccharide containing OMVs, but significantly reduced entry of non O                   
polysaccharide OMVs (Figure 5.7 G­I). It did not affect the maximum rate of uptake                           
(Figure 5.8 G­I). Filipin treatment significantly inhibited the efficiency of entry, and the                         
maximum rate of uptake of both sets of OMVs (Figure 5.8 G­I). The difference in the                               
apparent efficacy of filipin treatment between EAEC and K12 may be due to the higher                             











Hela cells were either left untreated (control, red), or pre­treated with 5 mM                         
methyl­β­cyclodextrin (light green) or 1 µg/ml filipin (turquoise)and exposed to ClyA­Bla                     
OMVs isolated from EHEC (A­C), EAEC (D­F) or K12 (G­I) with (red) or without (blue)                             
O polysaccharide at an MOI of 1000 for 3 hours. OMV uptake (Y axis) is defined as the                                   
ratio of blue:green fluorescence over 3h as an indication of entry of β­lactamase from the                             
reporter OMVs into host cells, where cleavage of CCF2­AM substrate then occurred.                       
Ratios were plotted as means ± stdev for 3 biological replicates with three technical                           
replicates. (A,B,D,E,G,H). Efficiency of uptake (C, F, I) was defined as the total change                           
in blue:green ratio over 3h from (A,B,D,E,G,H). ANOVA was used to analyse results,                         
with a Brown Forsythe test for equal variance. Replicates were treated as 9 independent                           
replicates, and corrected for multiple comparisons between samples. P value < 0.05 was                         
150 





Figure 5.8. Rate of entry for OMVs is reduced in the absence of lipid raft mediated                               
endocytosis 
To determine rate of OMV entry, polynomials were fitted to each FRET data set in Figure                               
5.7 (A,B,D,E,G,H) using the cubic spline function csaps in Matlab. Numerical estimates                       
of the gradients of the resulting polynomials were determined using the gradient function.                         
Data shown are means ± stdev for 3 biological replicates with three technical replicates.                           
Maximum rate of uptake (C, F and I) were determined from data in ( A,B,D,E,G,H ) as the                               
maximum change in gradient over 3h. Data shown are means ± stdev, with replicates                           
treated as 9 independent replicates. Significance was determined by ANOVA, with a                       
Brown Forsythe test to determine equal variance, and corrected for multiple comparisons                       




These data show that, while OMVs are able to access different uptake routes including                           
macropinocytosis, clathrin­dependent and raft­dependent endocytosis, OMVs displaying             
O polysaccharide on their surface are able to utilise raft­dependent endocytosis more                       
efficiently, and are more affected by its inhibition, while OMVs lacking O polysaccharide                         
are more reliant on clathrin­mediated uptake. Inhibition of receptor or clathrin mediated                       
endocytosis shifts a larger fraction of these O polysaccharide positive OMVs to use                         














Next it was considered whether purified LPS would compete with the OMVs for binding                           
sites on the host cell surface. Prior to infection with OMVs, HeLa cells were                           
pre­incubated with 1 μg/ml LPS from either smooth (O55:B5, core type R3) or rough                           
strains (EH100, no O polysaccharide, core type R2). Supplementation with LPS inhibited                       
the efficiency of uptake of EHEC OMVs, but had no significant effect on uptake of                             
OMVS from EAEC or K12 (Figure 5.10).  
 
Since LPS is known to associate with the host via TLR4, including in the HeLa tissue                               
culture cell line, inhibition of TLR4 by pre­treatment of cells with C34, a                         
2­acetamidopyranoside which competitively binds in the inner hydrophobic region of the                     
MD2 TLR4 co­receptor (Neal et al, 2013; Jiang et al, 2017) was used to determine if the                                 
EHEC OMVs required TLR4 binding in order to enter cells. C34 treatment did not inhibit                             
uptake of EHEC OMVs, suggesting that they are not competing for TLR4 (Figure 5.11)                           
(Neal et al, 2013). TLR4 activation also requires binding of CD14, a protein localised in                             
cholesterol rich lipid raft domains (Plociennikowska et al, 2015). EHEC OMVs were                       
previously shown to be highly dependent on the presence of host cell membrane                         
cholesterol for entry into host cells, more so than the other strains (Figure 5.7­8). As it                               
was demonstrated that entry of EHEC OMVs is strongly dependent on cholesterol rich                         
regions of the membrane, it suggests that the inhibition of uptake observed with the                           






(A) Hela cells were either left untreated (red), or pre­treated with 1μg/ml rough LPS                           
(from EH100 Ra mutant strain, Sigma) (pale blue) or 1μg/ml smooth LPS (from E. coli                             
O55:B5, Sigma) (purple) and then exposed to ClyA­Bla OMVs with and without O                         
polysaccharide isolated from EHEC (A), EAEC (B) or K12 (C) at an MOI of 1000 for 3                                 
hours. Total FRET changes after 3 hrs were determined and plotted to visualize overall                           
efficiency of uptake into untreated Hela cells. Data shown are means ± stdev (n=3) and                             









(A) Hela cells were either left untreated (red), or pre­treated with 10 μM TLR4 inhibitor                             
C34 (orange) and exposed to ClyA­Bla OMVs isolated from EHEC with O                       
polysaccharide at an MOI of 1000 for 3 hours. OMV uptake (Y axis, (A),) is defined as                                 
the ratio of blue:green fluorescence over time, representing delivery of bla from OMVs                         
into HeLa cells where it can cause cleavage of CCF2­AM dye substrate. Data plotted as                             
mean ± stdev (n=3). 
(B) Total FRET changes after 3 hrs were determined from data in (A) and plotted to                               
visualize overall efficiency of uptake into untreated Hela cells (red), or cells pre­treated                         
with C34. Data shown are means ± stdev (n=3) and significance was determined by                           









The newly­devised assay was used to identify the relative contribution of cellular uptake                         
pathways to OMV entry into host cells. Assays using pharmacological inhibitors to block                         
specific endocytic pathways, showed that while all OMVs use multiple uptake routes,                       
their surface structure biases them towards different pathways. For example, O                     
polysaccharide deficient OMVs had a stringent requirement for surface protein receptors                     
for their uptake, while O polysaccharide containing OMVs were able to access                       
protein­receptor independent pathways. Depletion of such receptors actually allowed                 
them to access protein­receptor independent pathways more efficiently and utilize                   
raft­mediated endocytosis, a more rapid mode of uptake, as main route of entry. While                           
raft­mediated endocytic routes are not as well characterized as clathrin­mediated                   
endocytosis, it is clear there are multiple pathways, including caveolin and non­caveolin                       
dependent raft­mediated endocytosis. Many previous studies have used co­localisation                 
microscopy experiments to determine the route of OMV entry; this assay demonstrates                       
that internalisation occurs within minutes, and that visualisation of these processes would                       
require fixation of these cells almost immediately after infection, meaning that                     
microscopy is unsuitable for fully understanding the kinetics of OMV entry.  
Inhibition of receptor­mediated endocytosis by treatment of cells with papain resulted in                       
a significantly increased rate of uptake for EHEC, but a significant reduction in entry for                             
OMVs from EHEC without O polysaccharide. For OMVs from K12, there was no change                           
in rate but an increased total uptake, suggesting a change in the OMV entry phenotype in                               
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 the presence of O polysaccharide. This indicates that OMVs without O polysaccharide                       
rely on protein receptors and clathrin­ mediated endocytosis in order to gain access to the                             
host cell, whilst OMVs with O polysaccharide are not inhibited by the loss of this                             
pathway. It may be that the presence of the O polysaccharide could lead to possible                             
ligands in the inner regions of the LPS being obscured, whereas these potential receptor                           
binding regions are exposed in the absence of O polysaccharide, and interestingly, loss of                           
the receptor­mediated pathway is beneficial to EHEC, and this may be due to a                           
preference for the non­receptor mediated pathways which allow for more efficient cargo                       
delivery from OMVs.  
 
When lipid raft mediated endocytosis was inhibited with methyl­ß­cyclodextrin or filipin,                     
total uptake of OMVs from all three strains was reduced, but the relative decrease in                             
efficiency was largest for EHEC OMVs, which also showed a significant decrease in the                           
rate of uptake (Figure 3.8­9). This indicated that in contrast to K12, EHEC OMVs                           
preferentially utilize clathrin­ independent entry routes. Entry was also shown to be                       
strongly dynamin­dependent, suggesting OMVs containing O polysaccharide are also                 
taken up by caveolin­mediated endocytosis. OMVs from EHEC are known to contribute                       
to infection via delivery of diverse virulence factors, and this may be a further adaptation                             
to pathogenesis for EHEC, as although the rate of internalization by caveolae is around 5                             
times slower than that of clathrin­dependent endocytosis, unlike clathrin­coated pits,                   
caveolae do not enter endocytic trafficking routes, and thus are not targeted to lysosomes                           
for processing or degradation (Ritter et al, 1995; Bielaszewska et al, 2013). Instead, the                           
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 contents of caveolae rapidly diffuse into the cytoplasm, consistent with the observation of                         
a rapid increase in cytoplasmic dye cleavage and thus, rapid increase in FRET almost                           
immediately after vesicle addition to cells. This suggests that internalization via                     
caveolin­mediated endocytosis allows more efficient delivery of cargo into a host cell                       
(Ritter et al, 1995). When clathrin­mediated endocytosis is inhibited, it becomes                     
obligatory for OMVs to utilise the more efficient caveolin pathway, which would explain                         
the increased total change in blue fluorescence observed for EHEC OMVs when cells are                           
treated with papain or chlorpromazine. It may be that OMVs from K12 lacking O­antigen                           
are less well adapted to using this route, and the presence of the O polysaccharide on                               
OMVs from K12 enhances their ability to use the alternative lipid raft­mediated route of                           
entry (Figure 3.8).  
 
EAEC OMVs displayed an intermediate phenotype between EHEC and K12 OMVs;                     
Loss of receptor mediated endocytosis caused an increased efficiency of uptake for O                         
polysaccharide positive OMVs, and a reduction for O polysaccharide negative OMVs,                     
but did not affect the maximum rate, similar to EHEC (Figure 3.6, 3.7). Treatment with                             
raft inhibitors had a less pronounced inhibition of uptake compared with EHEC, and did                           
not affect the maximum rate, unlike for both EHEC and K12 (Figure 3.8, 3.9). The                             
difference in preference of route of uptake may be due to the variation in the size of                                 
OMVs between the strains; the average diameter of EAEC OMVs was considerably                       
larger (102 nm) than EHEC or K12 OMVs (79 nm and 91 nm respectively), and since the                                 
diameter of caveolae is typically 50­80 nm, this may preclude larger vesicles from entry                           
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 via this pathway (Wang et al, 2009). Caveolae are able to accommodate larger (100­200                           
nm) particles, but their uptake is 5­10 times less efficient than for particles of <40 nm,                               
and they can internalise several smaller particles simultaneously (Wang et al, 2009).                       
Clathrin coated pits can readily endocytose particles of up to 200 nm (Vercauteren et al,                             
2010). Therefore the size distribution of OMVs may bias them towards entry through                         
certain uptake pathways.  
 
Chemical inhibition of endocytic pathways are commonly used, but these inhibitors are                       
also known to have a wide range of off target effects and can also cause cytotoxicity                               
(Preta et al, 2015). No positive controls were used for these inhibitors in this work, but                               
the concentrations used were previously verified in HeLa cells (Papatheodorou et al,                       
2010; Contreras et al, 2010; Girard et al, 2011; Ilnytska et al, 2013). Mycoplasma                           
contamination was also only checked twice throughout the project; this may also have                         
had a wide range of effects on cellular behaviour. 
 
Previous work with  H. pylori OMVs had indicated an inhibitory role of extracellular LPS                           
on OMV uptake (Parker et al, 2010). In these experiments, it was found that addition of                               
purified LPS, from either rough or smooth strains, resulted in significant inhibition of                         
uptake of EHEC OMVs, but had no effect on uptake of OMVs from K12 or EAEC. LPS                                 
is recognised by the TLR4 receptor on the host cell membrane, which can then drive                             
internalisation, but activation of this receptor requires binding of LPS to the CD14                         
protein which is associated with lipid raft microdomains and caveolae (Shuto et al, 2005;                           
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 Plociennikowska et al, 2015). EHEC OMVs were found to be strongly dependent on lipid                           
rafts for their entry, and were most affected by inhibition of this pathway with cholesterol                             
sequestering agents (Figure 5.7). Inhibition of TLR4 using C34, a small molecule which                         
competitively binds the TLR4­MD2 complex, had no significant effect on uptake of                       
OMVs (Figure 5.11) (Neal et al, 2013). This indicates that the reduction in uptake                           
observed for EHEC OMVs in the presence of supplementary LPS is not due to                           
competition for TLR4 binding. In addition, it is also shown that removal of surface                           
receptors resulted in an increased rate of uptake for EHEC OMVs, suggesting they are                           
not dependent on receptor mediated endocytosis (Figure 5.6). It is concluded that EHEC                         
OMVs are competing with purified LPS for cholesterol rich domains of the cell                         
membrane, rather than competing for the TLR4 receptor. Although HeLa cells are known                         
to express TLR4, and the C34 inhibitor is verified in HeLa cells, no positive control was                               
used to confirm the activity of the inhibitor (Neal et al, 2013; Jiang et al, 2017; Dowaidar                                 
et al, 2017). 
 
Other studies examining the routes of entry for OMVs and subsequent delivery on their                           
cargo have often produced contradictory findings; this may be a result of discrepancies                         
between the methods used in these studies. The methods developed earlier in this work                           
have provided a platform for study of OMV entry kinetics that overcomes the issues with                             
many of the methods used previously, by allowing real time, sensitive analysis of                         
technical replicates. A single well in a 96 well plate can contain up to 20,000 cells, and                                 
the use of the plate reader allows for averaging of the fluorescence emissions from these                             
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 cells every 90 seconds. Generating this amount of data using microscopy would be                         
unfeasible. 
 
The previous chapter identified a role for O polysaccharide in increasing the efficiency of                           
OMV uptake. The methods used here have demonstrated that O polysaccharide enhances                       
OMV uptake and cargo delivery due to creating a bias towards the non­receptor mediated                           
routes of cellular entry. In all cases, loss of receptor mediated endocytosis in the presence                             
of O polysaccharide OMVs caused an increase in their uptake, suggesting a shift towards                           
lipid raft or caveolin mediated endocytosis that enhanced the efficiency of OMV uptake                         
and delivery of their contents. This is independent of TLR4 binding. This suggests that                           
the presence of O polysaccharide on the OMVs of pathogenic strains is a useful                           
adaptation that increases their ability to deliver virulence factors and enhance                     
pathogenicity.  
 
Understanding these uptake processes is vital in order to be able to inhibit the delivery of                               
their toxic cargo during infection, but their affinity for host cells can also be used to our                                 
advantage. Artificial liposomes are already being explored as a drug delivery tool; OMVs                         
are essentially naturally produced liposomes, and they too could be repurposed for                       







The data presented in this work has developed a much­needed novel method for                         
monitoring the entry of bacterial outer membrane vesicles into host cells, and this                         
revealed that the O polysaccharide component of OMVs created a bias towards non                         
receptor mediated endocytosis, resulting in enhanced efficiency of uptake. The entry of                       
OMV cargo directly into the host cell is associated with pathogenesis, via the delivery of                             
numerous bacterial virulence factors (Kesty et al, 2004; Yoon et al, 2016). Many of these                             
virulence factors are preferentially exported by OMVs, rather than via other bacterial                       
secretion systems (Kato et al, 2002; Wai et al, 2003).  
 
In the method described here, the preferential targeting of the pore forming cytolysin,                         
ClyA, into OMVs is exploited as a means to export the reporter component, the                           
β­lactamase enzyme (Kim et al, 2008). Entry of β­lactamase into host cells pre­loaded                         
with CCF2­AM dye allows it to cleave the cephalosporin ring linking the fluorescein and                           
coumarin molecules, resulting in their spatial separation, a disruption to FRET and a                         
detectable change in emission from 530 nm to 460 nm. The use of the CCF2­AM FRET                               
system has been described previously to monitor secretion of bacterial effector                     
molecules, and in viral infections and drug screening, but this is the first time it has been                                 
adapted to study OMVs (Cavrois et al, 2002; Mills et al, 2008; Landowski et al, 2014).   
 
Use of this assay has allowed continuous, real­time monitoring of OMV entry into host                           
cells, in a sensitive manner. The method also generates robust and repeatable data,                         
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 through the use of a multi­well plate format, which unlike other methods of study has                             
allowed multiple conditions and repeats to be tested simultaneously. Whilst this assay has                         
been tested in various strains of  E. coli , further work will be necessary to determine                             
whether ClyA can also be successfully targeted into other distantly related strains, which                         
do not naturally express ClyA (Kim et al, 2008).  
 
The small size of OMVs has made study of their entry problematic; their size range of                               
20­200 nm means that conventional methods of light microscopy are unable to detect the                           
whole population of vesicles. The resolution limit of confocal microscopy is                     
approximately 180 nm (Heintzmann and Ficz, 2013). This could result in conclusions                       
being made which do not reflect the full repertoire of interactions between OMVs and the                             
host cell; this work showed that OMVs can use multiple entry pathways. The size of                             
OMVs is likely to influence their mechanism of uptake. Macropinocytosis can facilitate                       
ingestion of particles up to 1 μm, whilst clathrin mediated endocytosis can internalise                         
vesicles with a diameter of up to 120 nm. Caveolae and lipid rafts generally allow entry                               
of molecules smaller than 100 nm in diameter (Parton et al, 2007; Amano et al, 2010).                               
This method allowed monitoring of a wider population of vesicles, as detection required                         
entry of β­lactamase rather than visualisation of vesicles, and used measurement of the                         
intracellular change in fluorescence in the host cell instead. Future work could isolate                         




 This method relies on delivery of β­lactamase cargo from the vesicles into the host cells,                             
rather than the labelling of the OMVs. It is not clear how many molecules of β­lactamase                               
were exported into a single vesicle, and whether this value would change if the size of the                                 
OMV was altered. Immunogold labelling of the OMVs would be necessary to determine                         
the number of β­lactamase molecules present per vesicle. It is also unknown how many                           
β­lactamase molecules need to enter the host cell in order to cause sufficient dye cleavage                             
for a detectable change in emission. It is likely that the efficiency or rate of OMV entry                                 
varies amongst the host cells. The use of the plate reader allows for averaging of the                               
fluorescence in each well, where up to 20,000 cells are present, and so this generates a                               
large amount of data to determine the average level of OMV entry. It would be unfeasible                               
to obtain the equivalent amount of data from microscopy alone.  
 
In addition, methods which use labelling of specific OMV epitopes may neglect some                         
subpopulations of OMVs, and the use of lipophilic dyes could affect the behaviour of the                             
OMVs themselves, by interference with the lipid membrane (Lulevich et al, 2009).                       
OMVs were shown to enter the cells rapidly, with disruption to FRET occurring within                           
minutes. This suggested that there is no significant delay between the entry of                         
β­lactamase, cleavage of the substrate and its detection by the plate reader, but also that                             
other means of determining the kinetics of OMV uptake are impractical; fixing cells at                           
these early time points would be difficult, whilst live imaging may result in only the                             
later­entering OMV populations being detected or quantified, meaning that the overall                     
kinetic data may be skewed.  
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 With modifications to allow bacterial expression of the esterases required to retain the                         
FRET substrate, this system could also be adapted to monitor the delivery of OMVs                           
between bacterial cells (Nord et al, 2005). Inter­bacterial delivery of OMVs is a process                           
which is observed in mixed bacterial communities and can enable bacteria to compete                         
within a niche by release of toxins and enzymes, and accelerate the spread of antibiotic                             
resistance through the transfer of resistance genes (Berleman and Auer, 2013; Chatterjee                       
et al, 2017). Expanding this method to characterise the interactions between OMVs and                         
bacterial cells could help to elucidate the roles of OMVs in bacterial communities. 
 
It was attempted to use this method  in vivo in a zebrafish model of infection, but there                                 
was no evidence of dye uptake in the embryo. Despite this, this assay still represents a                               
useful  in vitro  method of screening for factors which affect OMV uptake, and could also                             
be used to assist in developing OMV­based drug delivery vehicles. Fusion to ClyA                         
represents a verified method of targeting other molecules into OMVs, such as anti­cancer                         
drugs or siRNA, and therefore this assay could be used to observe their delivery into                             
tumour cells  in vitro , prior to use  in vivo (Kim et al, 2008; Gujrati et al, 2014). Transwell                                   
experiments also demonstrated that this method could be used without purification of                       




 This work showed that OMVs have a high affinity for mammalian host cells, as the MOI                               
used was equivalent to a bacterial MOI of 25, and the vesicles were able to enter and                                 
deliver cargo to HeLa cells. Efficient OMV delivery was also observed in RKO cells, a                             
human rectal carcinoma cell line, which represents a more biologically relevant setting as                         
E. coli  is commonly found in the intestinal tract (Savageau, 1983; Ahmed et al, 2013).                             
The data presented here indicated that the presence of O polysaccharide, the variable                         
component of the Gram negative outer membrane, is implicated in enhancing the ability                         
of OMVs to enter the host, which may be due to the presence of O polysaccharide                               
creating a bias towards different pathways of endocytosis. Presence of O polysaccharide,                       
in either the pathogenic (EHEC, EAEC) or non pathogenic (K12) strains used, resulted in                           
an increased uptake, in both HeLa and RKO cells. As cell surface proteins and the                             
abundance of lipid rafts can vary between different cell lines, it is compelling that the                             
effect of O polysaccharide was maintained across these two cell lines (Duncan et al,                           
2002).  
 
OMVs from EHEC and EAEC, both human pathogenic species of  E. coli , entered more                           
efficiently than those from the lab strain, K12. It may be that OMVs from pathogenic                             
species are better adapted to entering and delivering their cargo into host cells, and whilst                             
most research has focused on the behaviour of OMVs from pathogenic strains of bacteria,                           
previous studies have identified entry of OMVs from non pathogenic strains into host                         
cells (Canas et al, 2016). Restoration of the native O16 O polysaccharide in K12 was                             
demonstrated to enable it to become a pathogen of the nematode  Caenorhabditis elegans                         
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 (Browning et al, 2013). In this work, the OMVs from the K12 parent strain were able to                                 
enter host cells, but when O polysaccharide expression in K12 was restored, the rate and                             
efficiency of entry was significantly increased.  
 
Many strains readily lose their O polysaccharide when cultured in a laboratory                       
environment, indicating its presence is not necessary or advantageous in this setting, in                         
contrast to the natural environment, where the vast majority of Gram negative species                         
express O polysaccharide (Stevenson et al, 1994). Alongside its other described roles in                         
bacterial fitness in the wild, this work suggests that O polysaccharide is also involved in                             
enhancing the ability of OMVs to interact with the host. It seems likely that the role of                                 
OMVs in non pathogenic species is underestimated, particularly in the case of                       
commensals or probiotic species (Muraca et al, 2015). OMVs from the probiotic strain  E.                           
coli Nissle 1917 have been shown to reduce inflammation and symptoms of                       
inflammatory bowel disease (Canas et al, 2016; Fabrega et al, 2017). Bacteria such as                           
Salmonella species that can replicate and colonise in the necrotic tumour environment                       
have been explored as a potential anti­cancer treatment, but they themselves cause side                         
effects due to their endotoxicity, and use of modified LPS has been identified as a means                               
of reducing their immunogenicity (Stritzker et al, 2010). While much work has focused                         
on reducing endotoxicity, this work suggests that in order to maximise the affinity of                           
OMVs for host cells, O polysaccharide is required. Understanding the requirements for                       
OMV entry may help to enhance their ability to reduce tumour growth, as they can be                               
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 targeted to deliver specific molecules into tumour cells (Stritzker et al, 2010; Gujrati et al,                             
2014).  
 
The enhanced uptake observed in the presence of O polysaccharide was maintained for                         
the three different O polysaccharide serotypes tested (O157, O42 and O16). The presence                         
of O polysaccharide has been previously reported to enhance adhesion and virulence of                         
various species of Gram negatives, but its role had not been explored in the context of                               
OMVs before. As it comprises a significant structural component at the outer surface of                           
OMVs, it seems logical that its presence could influence the interactions with host cells.                           
The specific structure of these O polysaccharides was not analysed in this work, and it                             
would be useful to identify whether there are specific components of these O                         
polysaccharides that influence the interactions of OMVs with the host cell membrane. It                         
would also be interesting to express different O polysaccharides in these species, such as                           
expressing O157 in K12 to rule out the possibility of the OMV cargo affecting their                             
uptake.  
 
The fate of the O polysaccharide within the host cells was not studied in this work.                               
Delivery of LPS from EHEC OMVs into the cytosol has been reported, which led to                             
activation of the inflammatory caspase­11, resulting in cell death (Vanaja et al, 2016).                         
Their study showed that LPS from the OMVs is not exclusively detected via its                           
interactions with TLR4, and instead was detected in the cytosol via inflammatory                       
caspases. Similarly, our work demonstrated that entry of OMVs was TLR4 independent,                       
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 with no effect on uptake observed with the use of a TLR4 inhibitor. The behaviour and                               
effect of OMVs on the host is not just a consequence of the high concentration of LPS;                                 
inoculation of mice with equivalent or higher amounts of LPS did not elicit the same                             
level of lethality as OMVs (Park et al, 2010). It may be that the presence of LPS in the                                     
context of OMVs does not interact with the host in the same way as purified or                               
cell­associated LPS. The use of OMVs in vaccine preparations and as adjuvants requires                         
a balance between immunogenicity and toxicity, and therefore understanding how the                     
specific components of LPS, including O polysaccharide, influence these responses is                     
vital in order to further their potential medical applications (Collins, 2011; Vanaja et al,                           
2016).  
 
The assay developed in this work revealed that OMVs can utilise multiple modes of entry                             
into the host cell, but also that their LPS composition alters their affinity for these                             
pathways. OMVs without O polysaccharide were more reliant on receptor mediated                     
endocytosis, whilst those with O polysaccharide were unaffected by inhibition of receptor                       
mediated endocytosis, and instead were dependent on lipid rafts. The protrusion of O                         
polysaccharide from LPS can obstruct the exposure of surface antigens, such as PgtE in                           
S. enterica , and Pla in  Y. pestis , affecting their ability to adhere and invade host cells                               
(Kukkonen et al, 2004). It may be that the presence of O polysaccharide on OMVs has a                                 
similar effect, and obscures potential host cell binding ligands, and so alternative entry                         
routes are used instead. Entry via non receptor mediated endocytosis can be advantageous                         
for pathogens as, although generally a slower route of entry, some evidence suggests that                           
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 the cargo entering the cell via this method is more likely to be released into the cytoplasm                                 
without degradation (Ritter et al, 1995; Bielaszewska et al, 2013; Lim et al, 2014). This                             
may explain why the rate and efficiency of uptake for O polysaccharide containing                         
OMVs was increased in the absence of receptor mediated endocytosis, as it forced a                           
larger proportion of vesicles to utilise alternative routes, resulting in increased cytosolic                       
exposure of β­lactamase to the FRET substrate.  
 
Chemical inhibition of endocytic uptake routes was used in this study. Although these                         
methods are well­established, it is possible that use of inhibitors against dynamin, clathrin                         
and cholesterol have other off­target effects, and it may be useful in the future to use                               
siRNA to silence the relevant genes in the host cell instead (Awasthi­Kalia et al, 2001;                             
Vercauteren et al, 2010). However, if there were side effects of the inhibitor treatments, it                             
would be expected to affect all the cells equally, which does not explain why differences                             
in uptake were observed between cells infected with OMVs with or without O                         
polysaccharide.  
 
Presence of O polysaccharide may not be the only factor affecting OMV entry, but it had                               
a significant effect for all the serotypes studied, and considering the heterogeneity of                         
OMV production, cargo and behaviour, it is compelling that this single factor had such a                             
profound effect. It remains to be seen if this is conserved for species other than  E. coli , or                                   




This assay represents a platform for future studies into OMVs and their interactions with                           
host cells. This work did not explore the fate of the OMVs upon entry into host cells, or                                   
whether this differed for those containing O polysaccharide. Imaging flow cytometry is a                         
relatively new technique, combining the quantitative sorting power of flow cytometry                     
with microscopy, to allow for counting and analysis of colocalisation simultaneously, and                       
has begun to be utilised for study of extracellular vesicles (Lannigan and Erdbruegger,                         
2017). It has yet to be used to study bacterial vesicles, but could be compatible with the                                 
reporter assay used here. CCF2 loaded cells used in the infection experiments could be                           
isolated afterwards, and stained for O antigen in conjunction with particular organelles,                       
such as lysosomes or mitochondria, and quantitatively determine the fate of OMV                       
components within infected cells. 
 
A role for O polysaccharide was determined in this work, but three different structures                           
were used. As the O polysaccharides are highly variable, it would be useful to explore                             
whether there are particular sugar components or linkages that are more advantageous for                         
cell entry, and to determine the effect of the number of repeat units. Engineering K12 to                               
express O157 would also elucidate whether the effect on cell entry is influenced by the                             




 One theory of OMV biogenesis suggests that the membrane composition influences                     
OMV production and cargo (Li et al, 1996); analysis of the OMV cargo would also allow                               
insight into whether the O polysaccharide affects the molecules packaged into the                       
vesicles. 
 
ClyA is used in this system in order to target the β­lactamase enzyme into the OMVs.                               
ClyA is conserved amongst many  E. coli and  Shigella strains, with homologs in                         
Salmonella and  Klebsiella , but it is unclear whether its use in other distantly related                           
strains would still allow for targeting into vesicles (Fahie et al, 2013). The use of this                               
assay would be significantly expanded if it was compatible with more Gram negative                         
species, to gain further appreciation of the interactions between OMVs and the host, but                           
also to determine how universal the effect of the O polysaccharide is.  
One of the most promising results in this work was the transwell assay, which showed                             
that OMVs could be delivered and detected entering host cells without prior isolation                         
from the bacterial culture. This removes a significant challenge of OMV research, and a                           
source of the potential discrepancies observed between studies, and also represents a                       
more realistic infection model. Future work could determine the ability of OMVs to enter                           
cells from cultures grown in different media, or from different growth phases. Since                         
OMVs are considered to be important contributors to pathogenicity, it could also be used                           
to examine the effect of antibiotics or stress on OMV delivery, and determine whether                           




Although this work focused on the delivery of OMVs from bacteria to the host, OMVs                             
are also delivered between bacteria, and play numerous roles in communities, such as                         
removing competing species, or delivering antibiotic resistance enzymes and genes ( Li et                       
al, 1998; Chatterjee et al, 2017). Bacteria lack the esterases required for CCF2 dye                           
retention in the cytoplasm, but engineering strains to express these enzymes may allow                         
use of this system, and monitoring of colour change to determine OMV entry (Nord et al,                               
2005). 
 
Type VI secretion is used by many Gram negatives to target bacteria occupying the same                             
niche (Ho et al, 2017). Preliminary experiments alongside this work showed that EHEC                         
mutants lacking a Type III secretion system produced more OMVs, and that T3SS                         
effector molecules were detected in the isolated OMV fractions from these mutants,                       
suggesting that OMVs can act as a compensatory secretion system. Future work to                         
develop this assay to detect delivery of reporter OMVs into bacterial cells could                         




This work has developed a novel method for studying the entry kinetics of OMVs, and                             
the endocytic mechanisms which facilitate these processes. The role of OMVs in health                         
and disease has been under explored, often due to methodological limitations or                       
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 inconsistencies in the data. This method overcomes these limitations and provides a                       
platform for further study of OMVs and their interactions with host cells, but it could also                               
be expanded, with modifications, to studying the role of OMVs within bacterial                       
communities, where they are known to contribute to biofilm formation, quorum sensing                       
and DNA transfer (Haurat et al, 2015).  
 
This approach has identified a role of O polysaccharide in influencing the route of                           
uptake, and subsequently the efficiency of cargo delivery from OMVs into the host cell.                           
During infection, delivery of toxic cargo from OMVs is a significant contributor to                         
pathogenesis (Kesty et al, 2004; Park et al, 2010). Further understanding of the                         
mechanisms employed by OMVs in pathogenesis could allow development of inhibitors                     
or vaccines which target this process. It could also enable expansion of the uses of OMVs                               
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